,date,title,url
0,2003-04-23,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-23/600521_2003_1.pdf
1,2003-05-15,华海药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-05-15/600521_20030515_1.pdf
2,2003-05-22,华海药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-05-22/600521_20030522_1.pdf
3,2003-07-31,华海药业投资者关系管理制度,/disclosure/listedinfo/announcement/c/2003-07-31/600521_20030731_1.pdf
4,2003-07-31,华海药业半年报,/disclosure/listedinfo/announcement/c/2003-07-31/600521_2003_z.pdf
5,2003-08-05,华海药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-08-05/600521_20030805_1.pdf
6,2003-08-09,华海药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-08-09/600521_20030809_1.pdf
7,2003-10-22,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-22/600521_2003_3.pdf
8,2003-12-24,华海药业公告,/disclosure/listedinfo/announcement/c/2003-12-24/600521_20031224_1.pdf
9,2003-12-27,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2003-12-27/600521_20031227_1.pdf
10,2004-01-08,华海药业业绩预增提示公告,/disclosure/listedinfo/announcement/c/2004-01-08/600521_20040108_1.pdf
11,2004-01-08,华海药业集提示性公告,/disclosure/listedinfo/announcement/c/2004-01-08/600521_20040108_2.pdf
12,2004-03-09,华海药业重大会计差错更正专门意见公告,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_11.pdf
13,2004-03-09,华海药业治理纲要修改议案,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_7.pdf
14,2004-03-09,华海药业召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_9.pdf
15,2004-03-09,华海药业章程修改议案,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_6.pdf
16,2004-03-09,华海药业年报,/disclosure/listedinfo/announcement/c/2004-03-09/600521_2003_n.pdf
17,2004-03-09,华海药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_10.pdf
18,2004-03-09,华海药业独立董事工作制度,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_2.pdf
19,2004-03-09,华海药业董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_5.pdf
20,2004-03-09,华海药业董事会人力资源委员会工作细则,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_4.pdf
21,2004-03-09,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_8.pdf
22,2004-03-09,华海药业董事会发展战略委员会工作细则,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_3.pdf
23,2004-03-09,华海药业董事会财务委员会工作细则,/disclosure/listedinfo/announcement/c/2004-03-09/600521_20040309_1.pdf
24,2004-03-30,华海药业关于2003年度股东大会会议地点变更公告,/disclosure/listedinfo/announcement/c/2004-03-30/600521_20040330_1.pdf
25,2004-04-03,华海药业第一次回访报告,/disclosure/listedinfo/announcement/c/2004-04-03/600521_20040403_1.pdf
26,2004-04-03,华海药业2004年第一季度业绩预增提示性公告,/disclosure/listedinfo/announcement/c/2004-04-03/600521_20040403_2.pdf
27,2004-04-03,华海药业2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-04-03/600521_20040403_3.pdf
28,2004-04-13,华海药业上市公司章程,/disclosure/listedinfo/announcement/c/2004-04-13/600521_20040413_g.pdf
29,2004-04-13,华海药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-13/600521_20040413_3.pdf
30,2004-04-13,华海药业公司治理纲要,/disclosure/listedinfo/announcement/c/2004-04-13/600521_20040413_5.pdf
31,2004-04-13,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-13/600521_20040413_2.pdf
32,2004-04-13,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-13/600521_2004_1.pdf
33,2004-04-13,华海药业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-04-13/600521_20040413_1.pdf
34,2004-04-13,华海药业2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-04-13/600521_20040413_4.pdf
35,2004-04-26,华海药业2003年度利润分配及转增股本实施公告,/disclosure/listedinfo/announcement/c/2004-04-26/600521_20040426_1.pdf
36,2004-07-06,华海药业2004年半年度业绩预增提示公告,/disclosure/listedinfo/announcement/c/2004-07-06/600521_20040706_1.pdf
37,2004-07-30,华海药业董事会议事规则,/disclosure/listedinfo/announcement/c/2004-07-30/600521_20040730_2.pdf
38,2004-07-30,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-07-30/600521_20040730_1.pdf
39,2004-07-30,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2004-07-30/600521_2004_zzy.pdf
40,2004-07-30,华海药业半年报,/disclosure/listedinfo/announcement/c/2004-07-30/600521_2004_z.pdf
41,2004-08-17,华海药业重大事项公告,/disclosure/listedinfo/announcement/c/2004-08-17/600521_20040817_1.pdf
42,2004-08-31,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-31/600521_20040831_1.pdf
43,2004-09-22,华海药业关于2004年第三季度业绩预增提示性公告,/disclosure/listedinfo/announcement/c/2004-09-22/600521_20040922_1.pdf
44,2004-10-09,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-10-09/600521_20041009_1.pdf
45,2004-10-22,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-22/600521_2004_3.pdf
46,2004-11-24,华海药业短期投资的公告,/disclosure/listedinfo/announcement/c/2004-11-24/600521_20041124_1.pdf
47,2005-01-24,华海药业2004年度业绩预增提示公告,/disclosure/listedinfo/announcement/c/2005-01-24/600521_20050124_1.pdf
48,2005-03-08,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2005-03-08/600521_2004_nzy.pdf
49,2005-03-08,华海药业年报,/disclosure/listedinfo/announcement/c/2005-03-08/600521_2004_n.pdf
50,2005-03-08,华海药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-08/600521_20050308_2.pdf
51,2005-03-08,华海药业关于召开2004年度股东大会的通知,/disclosure/listedinfo/announcement/c/2005-03-08/600521_20050308_5.pdf
52,2005-03-08,华海药业独立董事关于在临海川南设立独立子公司及变更募集资金项目抗艾滋病病－那韦系列项目投资主体的独立意见公告,/disclosure/listedinfo/announcement/c/2005-03-08/600521_20050308_3.pdf
53,2005-03-08,华海药业独立董事关于经营管理层薪酬与奖励的独立意见公告,/disclosure/listedinfo/announcement/c/2005-03-08/600521_20050308_4.pdf
54,2005-03-08,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-08/600521_20050308_1.pdf
55,2005-03-11,华海药业变更募集资金投资主体的公告,/disclosure/listedinfo/announcement/c/2005-03-11/600521_20050311_1.pdf
56,2005-04-05,华海药业2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-04-05/600521_20050405_1.pdf
57,2005-04-11,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-11/600521_2005_1.pdf
58,2005-04-11,华海药业2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-04-11/600521_20050411_1.pdf
59,2005-04-11,华海药业2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-04-11/600521_20050411_2.pdf
60,2005-04-18,华海药业2004年度分红派息及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2005-04-18/600521_20050418_1.pdf
61,2005-06-20,华海药业有关股权分置改革试点重大事项公告,/disclosure/listedinfo/announcement/c/2005-06-20/600521_20050620_1.pdf
62,2005-07-05,华海药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2005-07-05/600521_20050705_1.pdf
63,2005-07-11,华海药业关于举行两场投资者沟通会的公告,/disclosure/listedinfo/announcement/c/2005-07-11/600521_20050711_1.pdf
64,2005-07-18,华海药业关于召开2005年第一次临时股东大会的第一次催告通知,/disclosure/listedinfo/announcement/c/2005-07-18/600521_20050718_1.pdf
65,2005-07-18,华海药业独立董事征集投票权报告书的第一次催告通知,/disclosure/listedinfo/announcement/c/2005-07-18/600521_20050718_2.pdf
66,2005-07-21,华海药业董事会决议公告暨临时股东大会修改提案公告,/disclosure/listedinfo/announcement/c/2005-07-21/600521_20050721_1.pdf
67,2005-07-22,华海药业关于举行股权分置改革网上投资者交流会的公告,/disclosure/listedinfo/announcement/c/2005-07-22/600521_20050722_1.pdf
68,2005-07-28,华海药业关于召开2005年第一次临时股东大会的第二次催告通知,/disclosure/listedinfo/announcement/c/2005-07-28/600521_20050728_1.pdf
69,2005-07-28,华海药业独立董事征集投票权报告书的第二次催告通知,/disclosure/listedinfo/announcement/c/2005-07-28/600521_20050728_2.pdf
70,2005-07-29,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2005-07-29/600521_2005_zzy.pdf
71,2005-07-29,华海药业半年报,/disclosure/listedinfo/announcement/c/2005-07-29/600521_2005_z.pdf
72,2005-08-01,华海药业关于召开2005年第一次临时股东大会的第三次催告通知,/disclosure/listedinfo/announcement/c/2005-08-01/600521_20050801_1.pdf
73,2005-08-01,华海药业独立董事公开征集投票权的第三次催告通知,/disclosure/listedinfo/announcement/c/2005-08-01/600521_20050801_2.pdf
74,2005-08-02,华海药业2005年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-08-02/600521_20050802_1.pdf
75,2005-08-08,华海药业2005年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-08-08/600521_20050808_1.pdf
76,2005-08-08,华海药业2005年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-08-08/600521_20050808_2.pdf
77,2005-08-10,华海药业股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2005-08-10/600521_20050810_1.pdf
78,2005-08-10,华海药业股票简称变更公告,/disclosure/listedinfo/announcement/c/2005-08-10/600521_20050810_2.pdf
79,2005-08-16,G华海控股股东关于计划增持公司社会公众股份的公告,/disclosure/listedinfo/announcement/c/2005-08-16/600521_20050816_2.pdf
80,2005-08-16,G华海股份结构变动公告,/disclosure/listedinfo/announcement/c/2005-08-16/600521_20050816_1.pdf
81,2005-10-29,G华海信息披露管理制度,/disclosure/listedinfo/announcement/c/2005-10-29/600521_20051029_2.pdf
82,2005-10-29,G华海募集资金管理制度,/disclosure/listedinfo/announcement/c/2005-10-29/600521_20051029_1.pdf
83,2005-10-31,G华海董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2005-10-31/600521_20051031_1.pdf
84,2005-10-31,G华海第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-31/600521_2005_3.pdf
85,2005-11-16,G华海关于被授予“国家环境友好企业”称号的公告,/disclosure/listedinfo/announcement/c/2005-11-16/600521_20051116_1.pdf
86,2005-12-02,G华海关于召开2006年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2005-12-02/600521_20051202_3.pdf
87,2005-12-02,G华海关于巡检问题的整改报告,/disclosure/listedinfo/announcement/c/2005-12-02/600521_20051202_2.pdf
88,2005-12-02,G华海董事会决议公告关于回购社会公众股份的决议公告,/disclosure/listedinfo/announcement/c/2005-12-02/600521_20051202_1.pdf
89,2005-12-29,G华海2006年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-12-29/600521_20051229_1.pdf
90,2006-01-05,G华海2006年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-01-05/600521_20060105_2.pdf
91,2006-01-05,G华海2006年第一次临时股东大会的决议公告,/disclosure/listedinfo/announcement/c/2006-01-05/600521_20060105_1.pdf
92,2006-01-06,G华海关于回购社会公众股份的债权人公告,/disclosure/listedinfo/announcement/c/2006-01-06/600521_20060106_1.pdf
93,2006-03-14,G华海年报摘要,/disclosure/listedinfo/announcement/c/2006-03-14/600521_2005_nzy.pdf
94,2006-03-14,G华海年报,/disclosure/listedinfo/announcement/c/2006-03-14/600521_2005_n.pdf
95,2006-03-14,G华海监事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-14/600521_20060314_2.pdf
96,2006-03-14,G华海关于召开2005年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2006-03-14/600521_20060314_3.pdf
97,2006-03-14,G华海董事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-14/600521_20060314_1.pdf
98,2006-03-14,G华海2005年度关联方占用资金情况的专项审计说明,/disclosure/listedinfo/announcement/c/2006-03-14/600521_20060314_4.pdf
99,2006-04-07,G华海增加股东大会临时提案及变更会议时间的公告,/disclosure/listedinfo/announcement/c/2006-04-07/600521_20060407_1.pdf
100,2006-04-20,G华海监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-20/600521_20060420_2.pdf
101,2006-04-20,G华海股东大会议事规则,/disclosure/listedinfo/announcement/c/2006-04-20/600521_20060420_4.pdf
102,2006-04-20,G华海公司章程,/disclosure/listedinfo/announcement/c/2006-04-20/600521_20060420_g.pdf
103,2006-04-20,G华海第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-20/600521_2006_1.pdf
104,2006-04-20,G华海2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-04-20/600521_20060420_3.pdf
105,2006-04-20,G华海2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-04-20/600521_20060420_1.pdf
106,2006-04-25,G华海董事会公告,/disclosure/listedinfo/announcement/c/2006-04-25/600521_20060425_1.pdf
107,2006-06-02,G华海关于社会公众股份回购进展情况的公告,/disclosure/listedinfo/announcement/c/2006-06-02/600521_20060602_1.pdf
108,2006-06-26,G华海董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-06-26/600521_20060626_1.pdf
109,2006-07-04,G华海关于社会公众股份回购进展情况的公告,/disclosure/listedinfo/announcement/c/2006-07-04/600521_20060704_1.pdf
110,2006-07-27,G华海半年报摘要,/disclosure/listedinfo/announcement/c/2006-07-27/600521_2006_zzy.pdf
111,2006-07-27,G华海半年报,/disclosure/listedinfo/announcement/c/2006-07-27/600521_2006_z.pdf
112,2006-08-02,G华海关于社会公众股份回购进展情况的公告,/disclosure/listedinfo/announcement/c/2006-08-02/600521_20060802_1.pdf
113,2006-09-04,G华海关于社会公众股份回购进展情况的公告,/disclosure/listedinfo/announcement/c/2006-09-04/600521_20060904_1.pdf
114,2006-09-15,G华海有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2006-09-15/600521_20060915_1.pdf
115,2006-10-10,华海药业关于社会公众股份回购进展情况的公告,/disclosure/listedinfo/announcement/c/2006-10-10/600521_20061010_1.pdf
116,2006-10-24,华海药业关于召开2006年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-10-24/600521_20061024_2.pdf
117,2006-10-24,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-10-24/600521_20061024_1.pdf
118,2006-10-24,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-24/600521_2006_3.pdf
119,2006-10-26,华海药业关于社会公众股份回购情况的公告,/disclosure/listedinfo/announcement/c/2006-10-26/600521_20061026_1.pdf
120,2006-11-02,华海药业关于注销已回购的社会公众股份的公告,/disclosure/listedinfo/announcement/c/2006-11-02/600521_20061102_1.pdf
121,2006-11-10,华海药业2006年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-11-10/600521_20061110_1.pdf
122,2006-11-16,华海药业公司章程（2006修订）,/disclosure/listedinfo/announcement/c/2006-11-16/600521_20061116_g.pdf
123,2006-11-16,华海药业2006年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-11-16/600521_20061116_1.pdf
124,2006-11-16,华海药业2006年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-11-16/600521_20061116_2.pdf
125,2007-01-05,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-01-05/600521_20070105_1.pdf
126,2007-03-22,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2007-03-22/600521_2006_nzy.pdf
127,2007-03-22,华海药业年报,/disclosure/listedinfo/announcement/c/2007-03-22/600521_2006_n.pdf
128,2007-03-22,华海药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_2.pdf
129,2007-03-22,华海药业监事会关于变更募集资金项目上海奥博生物医药技术有限公司投资方式的意见,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_5.pdf
130,2007-03-22,华海药业关于召开2006年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_6.pdf
131,2007-03-22,华海药业关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_8.pdf
132,2007-03-22,华海药业关于2006年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_9.pdf
133,2007-03-22,华海药业独立董事关于董事会换届的独立意见,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_3.pdf
134,2007-03-22,华海药业独立董事关于变更募集资金项目上海奥博生物医药技术有限公司投资方式的独立意见公告,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_4.pdf
135,2007-03-22,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_1.pdf
136,2007-03-22,华海药业变更募集资金投资方式的公告,/disclosure/listedinfo/announcement/c/2007-03-22/600521_20070322_7.pdf
137,2007-04-05,华海药业增加第三届董事会候选人的公告,/disclosure/listedinfo/announcement/c/2007-04-05/600521_20070405_1.pdf
138,2007-04-10,华海药业2006年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-04-10/600521_20070410_1.pdf
139,2007-04-16,华海药业2006年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-04-16/600521_20070416_2.pdf
140,2007-04-16,华海药业2006年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-04-16/600521_20070416_1.pdf
141,2007-04-17,华海药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-17/600521_20070417_2.pdf
142,2007-04-17,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-17/600521_20070417_1.pdf
143,2007-04-17,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-17/600521_2007_1.pdf
144,2007-05-21,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-05-21/600521_20070521_1.pdf
145,2007-06-05,华海药业2006年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2007-06-05/600521_20070605_1.pdf
146,2007-06-26,华海药业信息披露管理制度,/disclosure/listedinfo/announcement/c/2007-06-26/600521_20070626_3.pdf
147,2007-06-26,华海药业关于“加强上市公司治理专项活动”自查报告,/disclosure/listedinfo/announcement/c/2007-06-26/600521_20070626_4.pdf
148,2007-06-26,华海药业固体制剂（片剂）生产厂区与原料药生产厂区通过美国FDA认证的公告,/disclosure/listedinfo/announcement/c/2007-06-26/600521_20070626_2.pdf
149,2007-06-26,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-06-26/600521_20070626_1.pdf
150,2007-07-04,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-07-04/600521_20070704_1.pdf
151,2007-07-13,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2007-07-13/600521_20070713_1.pdf
152,2007-07-26,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2007-07-26/600521_2007_zzy.pdf
153,2007-07-26,华海药业半年报,/disclosure/listedinfo/announcement/c/2007-07-26/600521_2007_z.pdf
154,2007-08-10,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-08-10/600521_20070810_1.pdf
155,2007-08-13,华海药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-08-13/600521_20070813_1.pdf
156,2007-09-27,华海药业子公司管理制度,/disclosure/listedinfo/announcement/c/2007-09-27/600521_20070927_3.pdf
157,2007-09-27,华海药业内部审计制度,/disclosure/listedinfo/announcement/c/2007-09-27/600521_20070927_2.pdf
158,2007-09-27,华海药业关于专项治理的整改报告,/disclosure/listedinfo/announcement/c/2007-09-27/600521_20070927_5.pdf
159,2007-09-27,华海药业对外投资管理制度,/disclosure/listedinfo/announcement/c/2007-09-27/600521_20070927_4.pdf
160,2007-09-27,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-09-27/600521_20070927_1.pdf
161,2007-10-25,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-25/600521_2007_3.pdf
162,2007-11-14,华海药业固体制剂生产线通过欧盟GMP认证的公告,/disclosure/listedinfo/announcement/c/2007-11-14/600521_20071114_1.pdf
163,2007-12-21,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-12-21/600521_20071221_1.pdf
164,2007-12-29,华海药业监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-12-29/600521_20071229_2.pdf
165,2007-12-29,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2007-12-29/600521_20071229_1.pdf
166,2008-01-03,华海药业第二大股东股份减持公告,/disclosure/listedinfo/announcement/c/2008-01-03/600521_20080103_1.pdf
167,2008-01-07,华海药业第二大股东股份减持公告,/disclosure/listedinfo/announcement/c/2008-01-07/600521_20080107_1.pdf
168,2008-03-25,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2008-03-25/600521_2007_nzy.pdf
169,2008-03-25,华海药业年报,/disclosure/listedinfo/announcement/c/2008-03-25/600521_2007_n.pdf
170,2008-03-25,华海药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-25/600521_20080325_3.pdf
171,2008-03-25,华海药业关于召开2007年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-03-25/600521_20080325_2.pdf
172,2008-03-25,华海药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-25/600521_20080325_1.pdf
173,2008-03-25,华海药业2007年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2008-03-25/600521_20080325_4.pdf
174,2008-04-08,华海药业关于增加2007年年度股东大会临时提案的公告,/disclosure/listedinfo/announcement/c/2008-04-08/600521_20080408_1.pdf
175,2008-04-10,华海药业2007年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-04-10/600521_20080410_1.pdf
176,2008-04-15,华海药业2007年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-04-15/600521_20080415_2.pdf
177,2008-04-15,华海药业2007年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-04-15/600521_20080415_1.pdf
178,2008-04-23,华海药业年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2008-04-23/600521_2007_nzy.pdf
179,2008-04-23,华海药业年报（修订版）,/disclosure/listedinfo/announcement/c/2008-04-23/600521_2007_n.pdf
180,2008-04-23,华海药业关于2007年年度报告的修正公告,/disclosure/listedinfo/announcement/c/2008-04-23/600521_20080423_1.pdf
181,2008-04-23,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-23/600521_2008_1.pdf
182,2008-04-30,华海药业关于控股股东陈保华先生有关承诺的公告,/disclosure/listedinfo/announcement/c/2008-04-30/600521_20080430_1.pdf
183,2008-05-07,华海药业2007年度分红派息及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2008-05-07/600521_20080507_1.pdf
184,2008-05-14,华海药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2008-05-14/600521_20080514_1.pdf
185,2008-05-23,华海药业及公司股东陈保华先生向地震灾区捐赠的公告,/disclosure/listedinfo/announcement/c/2008-05-23/600521_20080523_1.pdf
186,2008-06-20,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-06-20/600521_20080620_1.pdf
187,2008-07-16,华海药业关于公司专项治理活动整改情况的报告,/disclosure/listedinfo/announcement/c/2008-07-16/600521_20080716_2.pdf
188,2008-07-16,华海药业董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-07-16/600521_20080716_1.pdf
189,2008-07-24,华海药业关于签订制剂委托加工协议的公告,/disclosure/listedinfo/announcement/c/2008-07-24/600521_20080724_1.pdf
190,2008-08-12,华海药业有限售条件的流通股上市流通的公告,/disclosure/listedinfo/announcement/c/2008-08-12/600521_20080812_1.pdf
191,2008-08-15,华海药业信息披露管理制度,/disclosure/listedinfo/announcement/c/2008-08-15/600521_20080815_2.pdf
192,2008-08-15,华海药业第三届第四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2008-08-15/600521_20080815_1.pdf
193,2008-08-15,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-15/600521_2008_zzy.pdf
194,2008-08-15,华海药业半年报,/disclosure/listedinfo/announcement/c/2008-08-15/600521_2008_z.pdf
195,2008-09-17,华海药业关于公司控股股东陈保华先生已履行相关承诺的公告,/disclosure/listedinfo/announcement/c/2008-09-17/600521_20080917_1.pdf
196,2008-09-26,华海药业第三届董事会第十二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2008-09-26/600521_20080926_1.pdf
197,2008-10-21,华海药业关于被认定为2008年第一批高新技术企业的公告,/disclosure/listedinfo/announcement/c/2008-10-21/600521_20081021_1.pdf
198,2008-10-27,华海药业重大信息内部报告制度,/disclosure/listedinfo/announcement/c/2008-10-27/600521_20081027_3.pdf
199,2008-10-27,华海药业内幕信息保密制度,/disclosure/listedinfo/announcement/c/2008-10-27/600521_20081027_2.pdf
200,2008-10-27,华海药业防范大股东资金占用的长效机制,/disclosure/listedinfo/announcement/c/2008-10-27/600521_20081027_4.pdf
201,2008-10-27,华海药业第三届董事会第十三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2008-10-27/600521_20081027_1.pdf
202,2008-10-27,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-27/600521_2008_3.pdf
203,2008-12-22,华海药业第三届董事会第十四次临时会议（通讯方式）决议公告,/disclosure/listedinfo/announcement/c/2008-12-22/600521_20081222_1.pdf
204,2008-12-30,华海药业关于召开2009年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-12-30/600521_20081230_2.pdf
205,2008-12-30,华海药业第三届第五次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2008-12-30/600521_20081230_1.pdf
206,2009-01-22,华海药业2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-01-22/600521_20090122_1.pdf
207,2009-01-23,华海药业2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-01-23/600521_20090123_1.pdf
208,2009-02-06,华海药业2009年度第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-02-06/600521_20090206_1.pdf
209,2009-02-06,华海药业2009年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-02-06/600521_20090206_2.pdf
210,2009-03-17,华海药业总经理工作细则,/disclosure/listedinfo/announcement/c/2009-03-17/600521_20090317_6.pdf
211,2009-03-17,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2009-03-17/600521_2008_nzy.pdf
212,2009-03-17,华海药业年报,/disclosure/listedinfo/announcement/c/2009-03-17/600521_2008_n.pdf
213,2009-03-17,华海药业关于召开2008年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-03-17/600521_20090317_3.pdf
214,2009-03-17,华海药业董事会审计委员会年度工作规程,/disclosure/listedinfo/announcement/c/2009-03-17/600521_20090317_5.pdf
215,2009-03-17,华海药业第三届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-17/600521_20090317_2.pdf
216,2009-03-17,华海药业第三届第六次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-17/600521_20090317_1.pdf
217,2009-03-17,华海药业2008年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2009-03-17/600521_20090317_4.pdf
218,2009-03-26,华海药业关于2008年年度股东大会临时提案的公告,/disclosure/listedinfo/announcement/c/2009-03-26/600521_20090326_1.pdf
219,2009-04-01,华海药业第三届董事会第十五次临时会议（通讯方式）决议公告,/disclosure/listedinfo/announcement/c/2009-04-01/600521_20090401_1.pdf
220,2009-04-02,华海药业2008年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-04-02/600521_20090402_1.pdf
221,2009-04-08,华海药业公司治理纲要,/disclosure/listedinfo/announcement/c/2009-04-08/600521_20090408_3.pdf
222,2009-04-08,华海药业2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-04-08/600521_20090408_2.pdf
223,2009-04-08,华海药业2008年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-04-08/600521_20090408_1.pdf
224,2009-04-21,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-21/600521_2009_1.pdf
225,2009-05-18,华海药业公告,/disclosure/listedinfo/announcement/c/2009-05-18/600521_20090518_1.pdf
226,2009-05-21,华海药业2008年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2009-05-21/600521_20090521_1.pdf
227,2009-07-09,华海药业股票期权激励计划（草案）摘要,/disclosure/listedinfo/announcement/c/2009-07-09/600521_20090709_3.pdf
228,2009-07-09,华海药业第三届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2009-07-09/600521_20090709_2.pdf
229,2009-07-09,华海药业第三届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2009-07-09/600521_20090709_1.pdf
230,2009-08-10,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-10/600521_2009_zzy.pdf
231,2009-08-10,华海药业半年报,/disclosure/listedinfo/announcement/c/2009-08-10/600521_2009_z.pdf
232,2009-10-26,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-26/600521_2009_3.pdf
233,2009-12-01,华海药业关于会计师事务所更名公告,/disclosure/listedinfo/announcement/c/2009-12-01/600521_20091201_1.pdf
234,2010-01-20,华海药业关于获得中央预算内投资补助资金的公告,/disclosure/listedinfo/announcement/c/2010-01-20/600521_20100120_1.pdf
235,2010-03-03,华海药业关于召开2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-03-03/600521_20100303_3.pdf
236,2010-03-03,华海药业独立董事征集投票权报告书,/disclosure/listedinfo/announcement/c/2010-03-03/600521_20100303_4.pdf
237,2010-03-03,华海药业第三届监事会第九次临时会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-03/600521_20100303_2.pdf
238,2010-03-03,华海药业第三届董事会第十九次临时会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-03/600521_20100303_1.pdf
239,2010-03-08,华海药业关于签订制剂委托加工协议的公告,/disclosure/listedinfo/announcement/c/2010-03-08/600521_20100308_1.pdf
240,2010-03-10,华海药业关于召开2010年第一次临时股东大会通知的提示性公告,/disclosure/listedinfo/announcement/c/2010-03-10/600521_20100310_1.pdf
241,2010-03-16,华海药业2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-03-16/600521_20100316_1.pdf
242,2010-03-18,华海药业2010年第一次临时股东大会会议资料（修订版）,/disclosure/listedinfo/announcement/c/2010-03-18/600521_20100318_1.pdf
243,2010-03-23,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2010-03-23/600521_2009_nzy.pdf
244,2010-03-23,华海药业年报,/disclosure/listedinfo/announcement/c/2010-03-23/600521_2009_n.pdf
245,2010-03-23,华海药业内幕信息知情人登记备案制度,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_8.pdf
246,2010-03-23,华海药业关于召开2009年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_3.pdf
247,2010-03-23,华海药业关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_4.pdf
248,2010-03-23,华海药业独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_7.pdf
249,2010-03-23,华海药业独立董事关于董事会换届的独立意见,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_5.pdf
250,2010-03-23,华海药业第三届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_2.pdf
251,2010-03-23,华海药业第三届第八次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_1.pdf
252,2010-03-23,华海药业2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_9.pdf
253,2010-03-23,华海药业2010年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_10.pdf
254,2010-03-23,华海药业2009年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2010-03-23/600521_20100323_6.pdf
255,2010-03-31,华海药业第三届董事会第二十次临时会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-31/600521_20100331_1.pdf
256,2010-04-02,华海药业关于2009年年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2010-04-02/600521_20100402_1.pdf
257,2010-04-10,华海药业2009年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-10/600521_20100410_1.pdf
258,2010-04-16,华海药业第四届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-16/600521_20100416_3.pdf
259,2010-04-16,华海药业第四届第一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-16/600521_20100416_2.pdf
260,2010-04-16,华海药业2009年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-04-16/600521_20100416_4.pdf
261,2010-04-16,华海药业2009年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-16/600521_20100416_1.pdf
262,2010-04-27,华海药业2009年利润分配及公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2010-04-27/600521_20100427_1.pdf
263,2010-04-30,华海药业董事、监事和高级管理人员持有并买卖本公司股票管理制度,/disclosure/listedinfo/announcement/c/2010-04-30/600521_20100430_2.pdf
264,2010-04-30,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-30/600521_2010_1.pdf
265,2010-04-30,华海药业第四届董事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-30/600521_20100430_1.pdf
266,2010-05-27,华海药业第四届董事会第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2010-05-27/600521_20100527_1.pdf
267,2010-06-29,华海药业第四届第二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2010-06-29/600521_20100629_1.pdf
268,2010-08-16,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-16/600521_2010_zzy.pdf
269,2010-08-16,华海药业半年报,/disclosure/listedinfo/announcement/c/2010-08-16/600521_2010_z.pdf
270,2010-10-20,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-20/600521_2010_3.pdf
271,2010-12-20,华海药业第四届董事会第五次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2010-12-20/600521_20101220_1.pdf
272,2011-02-09,华海药业关于签订重大合同的公告,/disclosure/listedinfo/announcement/c/2011-02-09/600521_20110209_1.pdf
273,2011-03-29,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2011-03-29/600521_2010_nzy.pdf
274,2011-03-29,华海药业年报,/disclosure/listedinfo/announcement/c/2011-03-29/600521_2010_n.pdf
275,2011-03-29,华海药业关于召开2010年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-03-29/600521_20110329_2.pdf
276,2011-03-29,华海药业关于关联交易的公告,/disclosure/listedinfo/announcement/c/2011-03-29/600521_20110329_4.pdf
277,2011-03-29,华海药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2011-03-29/600521_20110329_6.pdf
278,2011-03-29,华海药业第四届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-29/600521_20110329_3.pdf
279,2011-03-29,华海药业第四届第三次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-29/600521_20110329_1.pdf
280,2011-03-29,华海药业2011年第一季度业绩预告,/disclosure/listedinfo/announcement/c/2011-03-29/600521_20110329_5.pdf
281,2011-04-13,华海药业关于2010年年度股东大会召开地点变更的公告,/disclosure/listedinfo/announcement/c/2011-04-13/600521_20110413_1.pdf
282,2011-04-14,华海药业2010年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-04-14/600521_20110414_1.pdf
283,2011-04-20,华海药业关于股票期权激励计划预留期权授予相关事项的公告,/disclosure/listedinfo/announcement/c/2011-04-20/600521_20110420_4.pdf
284,2011-04-20,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-20/600521_2011_1.pdf
285,2011-04-20,华海药业第四届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-20/600521_20110420_3.pdf
286,2011-04-20,华海药业第四届第四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-20/600521_20110420_2.pdf
287,2011-04-20,华海药业2010年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-04-20/600521_20110420_5.pdf
288,2011-04-20,华海药业2010年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-04-20/600521_20110420_1.pdf
289,2011-05-04,华海药业2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-05-04/600521_20110504_1.pdf
290,2011-05-07,华海药业第四届董事会第六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2011-05-07/600521_20110507_1.pdf
291,2011-05-28,华海药业第四届董事会第七次临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-05-28/600521_20110528_1.pdf
292,2011-06-03,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2011-06-03/600521_20110603_1.pdf
293,2011-06-08,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2011-06-08/600521_20110608_1.pdf
294,2011-06-29,华海药业2011年半年度业绩预增公告,/disclosure/listedinfo/announcement/c/2011-06-29/600521_20110629_1.pdf
295,2011-08-08,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-08/600521_2011_zzy.pdf
296,2011-08-08,华海药业半年报,/disclosure/listedinfo/announcement/c/2011-08-08/600521_2011_z.pdf
297,2011-09-06,华海药业第四届第五次董事会会议决议公告暨召开公司2011年第一次临时股东大会会议的通知,/disclosure/listedinfo/announcement/c/2011-09-06/600521_20110906_1.pdf
298,2011-09-17,华海药业2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-09-17/600521_20110917_1.pdf
299,2011-09-23,华海药业2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-09-23/600521_20110923_1.pdf
300,2011-09-23,华海药业2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-09-23/600521_20110923_2.pdf
301,2011-10-24,华海药业第四届董事会第九次临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-10-24/600521_20111024_1.pdf
302,2011-10-24,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-24/600521_2011_3.pdf
303,2011-11-28,华海药业第四届第六次董事会会议决议公告暨召开公司2011年第二次临时股东大会会议的通知,/disclosure/listedinfo/announcement/c/2011-11-28/600521_20111128_1.pdf
304,2011-12-13,华海药业第四届董事会第十次临时会议决议暨关于取消召开2011年第二次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2011-12-13/600521_20111213_1.pdf
305,2012-01-17,华海药业2011年度业绩预增公告,/disclosure/listedinfo/announcement/c/2012-01-17/600521_20120117_1.pdf
306,2012-02-21,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2012-02-21/600521_2011_nzy.pdf
307,2012-02-21,华海药业年报,/disclosure/listedinfo/announcement/c/2012-02-21/600521_2011_n.pdf
308,2012-02-21,华海药业关于股票期权激励计划第二个行权期可行权的公告,/disclosure/listedinfo/announcement/c/2012-02-21/600521_20120221_4.pdf
309,2012-02-21,华海药业关于调整股票期权激励计划期权数量的公告,/disclosure/listedinfo/announcement/c/2012-02-21/600521_20120221_3.pdf
310,2012-02-21,华海药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2012-02-21/600521_20120221_5.pdf
311,2012-02-21,华海药业独立董事2011年度述职报告,/disclosure/listedinfo/announcement/c/2012-02-21/600521_20120221_6.pdf
312,2012-02-21,华海药业第四届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2012-02-21/600521_20120221_2.pdf
313,2012-02-21,华海药业第四届第七次董事会会议决议公告暨召开公司2011年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-02-21/600521_20120221_1.pdf
314,2012-03-06,华海药业第四届第八次董事会会议决议公告暨召开公司2012年第一次临时股东大会会议的通知,/disclosure/listedinfo/announcement/c/2012-03-06/600521_20120306_1.pdf
315,2012-03-17,华海药业2011年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-03-17/600521_20120317_1.pdf
316,2012-03-19,华海药业关于召开公司2012年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2012-03-19/600521_20120319_1.pdf
317,2012-03-22,华海药业2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-03-22/600521_20120322_1.pdf
318,2012-03-23,华海药业2011年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-03-23/600521_20120323_2.pdf
319,2012-03-23,华海药业2011年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-03-23/600521_20120323_1.pdf
320,2012-03-28,华海药业2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-03-28/600521_20120328_1.pdf
321,2012-03-28,华海药业2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-03-28/600521_20120328_2.pdf
322,2012-03-29,华海药业内幕信息知情人登记备案制度,/disclosure/listedinfo/announcement/c/2012-03-29/600521_20120329_3.pdf
323,2012-03-29,华海药业内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2012-03-29/600521_20120329_2.pdf
324,2012-03-29,华海药业第四届董事会第十一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-29/600521_20120329_1.pdf
325,2012-04-13,华海药业2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-04-13/600521_20120413_1.pdf
326,2012-04-17,华海药业第四届董事会第十二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2012-04-17/600521_20120417_1.pdf
327,2012-04-25,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-25/600521_2012_1.pdf
328,2012-04-25,华海药业第四届董事会第十三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-25/600521_20120425_1.pdf
329,2012-05-08,华海药业关于中国银行间市场交易商协会接受公司注册发行短期融资券的公告,/disclosure/listedinfo/announcement/c/2012-05-08/600521_20120508_1.pdf
330,2012-06-09,华海药业关于2012年度第一期短期融资券发行完成的公告,/disclosure/listedinfo/announcement/c/2012-06-09/600521_20120609_1.pdf
331,2012-07-04,华海药业关于股票期权激励计划第二个行权期行权情况及行权股份上市的提示性公告,/disclosure/listedinfo/announcement/c/2012-07-04/600521_20120704_1.pdf
332,2012-07-23,华海药业关于股东自行召开公司2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-07-23/600521_20120723_1.pdf
333,2012-07-23,华海药业关于对股东自行召开公司2012年第二次临时股东大会相关议案说明的公告,/disclosure/listedinfo/announcement/c/2012-07-23/600521_20120723_3.pdf
334,2012-07-23,华海药业2012年半年度业绩预告公告,/disclosure/listedinfo/announcement/c/2012-07-23/600521_20120723_2.pdf
335,2012-08-08,华海药业2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-08-08/600521_20120808_1.pdf
336,2012-08-08,华海药业2012年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-08-08/600521_20120808_2.pdf
337,2012-08-16,华海药业第四届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-16/600521_20120816_1.pdf
338,2012-08-20,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-20/600521_2012_zzy.pdf
339,2012-08-20,华海药业半年报,/disclosure/listedinfo/announcement/c/2012-08-20/600521_2012_z.pdf
340,2012-09-11,华海药业关于获得国家补助资金的提示性公告,/disclosure/listedinfo/announcement/c/2012-09-11/600521_20120911_1.pdf
341,2012-09-28,华海药业债务融资工具信息披露管理制度,/disclosure/listedinfo/announcement/c/2012-09-28/600521_20120928_2.pdf
342,2012-09-28,华海药业第四届董事会第十六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2012-09-28/600521_20120928_1.pdf
343,2012-10-26,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-26/600521_2012_3.pdf
344,2013-01-09,华海药业未来三年（2012-2014年）股东回报规划,/disclosure/listedinfo/announcement/c/2013-01-08/600521_20130109_2.pdf
345,2013-01-09,华海药业关于召开2013年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-01-08/600521_20130109_4.pdf
346,2013-01-09,华海药业关于控股股东股权质押公告,/disclosure/listedinfo/announcement/c/2013-01-08/600521_20130109_3.pdf
347,2013-01-09,华海药业第四届董事会第十八次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-01-08/600521_20130109_1.pdf
348,2013-01-10,华海药业2012年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2013-01-09/600521_20130110_1.pdf
349,2013-01-19,华海药业关于召开公司2013年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2013-01-18/600521_20130119_2.pdf
350,2013-01-19,华海药业2013年第一次临时股东大会资料,/disclosure/listedinfo/announcement/c/2013-01-18/600521_20130119_1.pdf
351,2013-01-22,华海药业关于公开增发方案获得证监会审核通过的公告,/disclosure/listedinfo/announcement/c/2013-01-21/600521_20130122_1.pdf
352,2013-01-24,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2013-01-23/600521_20130124_1.pdf
353,2013-01-26,华海药业2013年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-01-25/600521_20130126_1.pdf
354,2013-01-26,华海药业2013年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-01-25/600521_20130126_2.pdf
355,2013-02-22,华海药业审计报告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_13.pdf
356,2013-02-22,华海药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_4.pdf
357,2013-02-22,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2013-02-21/600521_2012_nzy.pdf
358,2013-02-22,华海药业年报,/disclosure/listedinfo/announcement/c/2013-02-21/600521_2012_n.pdf
359,2013-02-22,华海药业关于召开2012年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_5.pdf
360,2013-02-22,华海药业关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_3.pdf
361,2013-02-22,华海药业关于股票期权激励计划第三个行权期可行权的公告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_7.pdf
362,2013-02-22,华海药业关于调整股票期权激励计划期权数量的公告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_6.pdf
363,2013-02-22,华海药业独立董事关于公司对外担保、关联方资金往来及年度董事会召开程序、必备文件等的独立意见,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_11.pdf
364,2013-02-22,华海药业独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_12.pdf
365,2013-02-22,华海药业第四届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_2.pdf
366,2013-02-22,华海药业第四届第十次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_1.pdf
367,2013-02-22,华海药业：浙江星海律师事务所关于浙江华海药业股份有限公司股票期权激励计划相关事项调整及第三期行权相关事宜的法律意见书,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_9.pdf
368,2013-02-22,华海药业2012年度非经营性资金占用及其他关联方资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2013-02-21/600521_20130222_14.pdf
369,2013-03-08,华海药业验资报告,/disclosure/listedinfo/announcement/c/2013-03-07/600521_20130308_2.pdf
370,2013-03-08,华海药业关于股票期权激励计划第二个行权期激励对象申请行权情况及行权股份上市的提示性公告,/disclosure/listedinfo/announcement/c/2013-03-07/600521_20130308_1.pdf
371,2013-03-14,华海药业年报（修订版）,/disclosure/listedinfo/announcement/c/2013-03-13/600521_2012_n.pdf
372,2013-03-14,华海药业2012年年度报告补充公告,/disclosure/listedinfo/announcement/c/2013-03-13/600521_20130314_1.pdf
373,2013-03-20,华海药业关于控股股东股权质押公告,/disclosure/listedinfo/announcement/c/2013-03-19/600521_20130320_2.pdf
374,2013-03-20,华海药业2012年年度股东大会资料,/disclosure/listedinfo/announcement/c/2013-03-19/600521_20130320_1.pdf
375,2013-03-27,华海药业关于为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2013-03-26/600521_20130327_4.pdf
376,2013-03-27,华海药业第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/600521_20130327_3.pdf
377,2013-03-27,华海药业第五届第一次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/600521_20130327_2.pdf
378,2013-03-27,华海药业2012年年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2013-03-26/600521_20130327_5.pdf
379,2013-03-27,华海药业2012年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-03-26/600521_20130327_1.pdf
380,2013-03-30,华海药业验资报告,/disclosure/listedinfo/announcement/c/2013-03-29/600521_20130330_2.pdf
381,2013-03-30,华海药业关于股票期权激励计划第二个行权期激励对象申请行权情况及行权股份上市的提示性公告,/disclosure/listedinfo/announcement/c/2013-03-29/600521_20130330_1.pdf
382,2013-04-11,华海药业关于2012年度利润分配及转增股本实施公告,/disclosure/listedinfo/announcement/c/2013-04-10/600521_20130411_2.pdf
383,2013-04-16,华海药业关于2013年度第一期短期融资券发行情况的公告,/disclosure/listedinfo/announcement/c/2013-04-15/600521_20130416_1.pdf
384,2013-04-26,华海药业关于公开发行股票申请获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2013-04-25/600521_20130426_1.pdf
385,2013-04-27,华海药业关于制剂产品拉莫三嗪美国市场收益情况的公告,/disclosure/listedinfo/announcement/c/2013-04-27/600521_20130427_7.pdf
386,2013-04-27,华海药业关于调整股票期权激励计划期权数量及行权价格的公告,/disclosure/listedinfo/announcement/c/2013-04-27/600521_20130427_4.pdf
387,2013-04-27,华海药业调整股票期权数量及行权价格的法律意见书,/disclosure/listedinfo/announcement/c/2013-04-27/600521_20130427_6.pdf
388,2013-04-27,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-26/600521_2013_1.pdf
389,2013-04-27,华海药业第五届董事会第一次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-04-27/600521_20130427_3.pdf
390,2013-05-02,华海药业增发招股意向书摘要,/disclosure/listedinfo/announcement/c/2013-05-01/600521_20130502_5.pdf
391,2013-05-02,华海药业增发招股意向书,/disclosure/listedinfo/announcement/c/2013-05-01/600521_20130502_4.pdf
392,2013-05-02,华海药业增发A股网下发行公告,/disclosure/listedinfo/announcement/c/2013-05-01/600521_20130502_2.pdf
393,2013-05-02,华海药业增发A股网上路演公告,/disclosure/listedinfo/announcement/c/2013-05-01/600521_20130502_3.pdf
394,2013-05-02,华海药业增发A股网上发行公告,/disclosure/listedinfo/announcement/c/2013-05-01/600521_20130502_1.pdf
395,2013-05-04,华海药业第五届董事会第二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-05-03/600521_20130504_1.pdf
396,2013-05-06,华海药业增发A股提示性公告,/disclosure/listedinfo/announcement/c/2013-05-05/600521_20130506_1.pdf
397,2013-05-07,华海药业第五届董事会第三次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-05-06/600521_20130507_1.pdf
398,2013-05-09,华海药业增发A股网下发行结果及网上中签率公告,/disclosure/listedinfo/announcement/c/2013-05-08/600521_20130509_1.pdf
399,2013-05-10,华海药业增发A股网上中签结果公告,/disclosure/listedinfo/announcement/c/2013-05-09/600521_20130510_1.pdf
400,2013-05-21,华海药业公开增发A股股票上市公告书,/disclosure/listedinfo/announcement/c/2013-05-20/600521_20130521_1.pdf
401,2013-05-24,华海药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2013-05-23/600521_20130524_1.pdf
402,2013-06-15,华海药业关于获得药品注册批件的公告,/disclosure/listedinfo/announcement/c/2013-06-14/600521_20130615_1.pdf
403,2013-06-28,华海药业以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_8.pdf
404,2013-06-28,华海药业以募集资金置换已投入募集资金投资项目自筹资金之专项核查意见,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_9.pdf
405,2013-06-28,华海药业募集资金管理制度,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_6.pdf
406,2013-06-28,华海药业关于召开2013年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_3.pdf
407,2013-06-28,华海药业关于以公开增发股票募集资金置换预先已投入募集资金项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_5.pdf
408,2013-06-28,华海药业关于利用闲置自有资金进行委托理财或委托贷款业务的公告,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_4.pdf
409,2013-06-28,华海药业对外投资管理制度,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_7.pdf
410,2013-06-28,华海药业第五届监事会第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_2.pdf
411,2013-06-28,华海药业第五届董事会第四次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-06-27/600521_20130628_1.pdf
412,2013-07-02,华海药业股权激励计划行权结果暨股份上市公告,/disclosure/listedinfo/announcement/c/2013-07-01/600521_20130702_1.pdf
413,2013-07-11,华海药业2013年第二次临时股东大会资料,/disclosure/listedinfo/announcement/c/2013-07-10/600521_20130711_1.pdf
414,2013-07-13,华海药业委托贷款公告,/disclosure/listedinfo/announcement/c/2013-07-12/600521_20130713_1.pdf
415,2013-07-18,华海药业2013年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-07-17/600521_20130718_1.pdf
416,2013-07-18,华海药业2013年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-07-17/600521_20130718_2.pdf
417,2013-07-31,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2013-07-30/600521_20130731_1.pdf
418,2013-08-16,华海药业关于定期报告中董事持股数量的更正说明公告,/disclosure/listedinfo/announcement/c/2013-08-15/600521_20130816_4.pdf
419,2013-08-16,华海药业第五届监事会第三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-15/600521_20130816_2.pdf
420,2013-08-16,华海药业第五届董事会第五次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-08-15/600521_20130816_1.pdf
421,2013-08-16,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-15/600521_2013_zzy.pdf
422,2013-08-16,华海药业半年报,/disclosure/listedinfo/announcement/c/2013-08-15/600521_2013_z.pdf
423,2013-08-16,华海药业2013年半年度募集资金存放与实际使用情况专项报告,/disclosure/listedinfo/announcement/c/2013-08-15/600521_20130816_3.pdf
424,2013-09-07,华海药业使用暂时闲置的募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2013-09-06/600521_20130907_4.pdf
425,2013-09-07,华海药业关于使用暂时闲置的募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2013-09-06/600521_20130907_3.pdf
426,2013-09-07,华海药业第五届监事会第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-09-06/600521_20130907_1.pdf
427,2013-09-07,华海药业第五届董事会第六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-09-06/600521_20130907_2.pdf
428,2013-09-11,华海药业与军事医学科学院毒物药物研究所战略合作协议的公告,/disclosure/listedinfo/announcement/c/2013-09-10/600521_20130911_1.pdf
429,2013-09-12,华海药业关于使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2013-09-11/600521_20130912_1.pdf
430,2013-09-27,华海药业第五届董事会第七次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2013-09-26/600521_20130927_1.pdf
431,2013-10-09,华海药业关于获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2013-10-08/600521_20131009_1.pdf
432,2013-10-19,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2013-10-18/600521_20131019_1.pdf
433,2013-10-28,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-27/600521_2013_3.pdf
434,2013-11-11,华海药业关于大股东增持公司股份及短线交易的公告,/disclosure/listedinfo/announcement/c/2013-11-10/600521_20131111_1.pdf
435,2013-12-13,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2013-12-12/600521_20131213_2.pdf
436,2013-12-13,华海药业关于合作开发产品Humira单抗生物仿制药收到欧盟EMA及美国FDA允许开展一期临床试验的函件的公告,/disclosure/listedinfo/announcement/c/2013-12-12/600521_20131213_1.pdf
437,2013-12-19,华海药业关于使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2013-12-18/600521_20131219_1.pdf
438,2013-12-21,华海药业关于高管辞职的公告,/disclosure/listedinfo/announcement/c/2013-12-20/600521_20131221_1.pdf
439,2013-12-26,华海药业关于合作开发产品Avastin单抗生物仿制药收到欧盟EMA允许开展一期临床试验的函件的公告,/disclosure/listedinfo/announcement/c/2013-12-25/600521_20131226_1.pdf
440,2014-01-07,华海药业关于增加信息披露指定媒体的公告,/disclosure/listedinfo/announcement/c/2014-01-06/600521_20140107_1.pdf
441,2014-01-16,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2014-01-15/600521_20140116_1.pdf
442,2014-02-11,华海药业关于获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2014-02-10/600521_20140211_1.pdf
443,2014-02-13,华海药业关于公司股东、关联方及上市公司承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-12/600521_20140213_1.pdf
444,2014-03-19,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2014-03-18/600521_20140319_1.pdf
445,2014-03-25,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2014-03-24/600521_20140325_1.pdf
446,2014-04-01,华海药业组织结构管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_30.pdf
447,2014-04-01,华海药业外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_29.pdf
448,2014-04-01,华海药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_6.pdf
449,2014-04-01,华海药业企业文化管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_28.pdf
450,2014-04-01,华海药业企业风险评估制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_27.pdf
451,2014-04-01,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2014-03-31/600521_2013_nzy.pdf
452,2014-04-01,华海药业年报,/disclosure/listedinfo/announcement/c/2014-03-31/600521_2013_n.pdf
453,2014-04-01,华海药业内部审计制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_26.pdf
454,2014-04-01,华海药业会计核算制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_25.pdf
455,2014-04-01,华海药业关于召开2013年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_5.pdf
456,2014-04-01,华海药业关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_4.pdf
457,2014-04-01,华海药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_10.pdf
458,2014-04-01,华海药业发展战略管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_24.pdf
459,2014-04-01,华海药业对外捐赠与赞助管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_23.pdf
460,2014-04-01,华海药业对外担保管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_22.pdf
461,2014-04-01,华海药业独立董事关于公司对外担保情况、关联方资金往来的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_8.pdf
462,2014-04-01,华海药业独立董事关于第五届董事会第二次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_34.pdf
463,2014-04-01,华海药业独立董事关于第五届董事会第二次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_33.pdf
464,2014-04-01,华海药业独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_11.pdf
465,2014-04-01,华海药业董事会审计委员会工作细则,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_21.pdf
466,2014-04-01,华海药业董事会审计委员会2013年度履职情况报告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_18.pdf
467,2014-04-01,华海药业第五届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_3.pdf
468,2014-04-01,华海药业第五届第二次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_2.pdf
469,2014-04-01,华海药业筹资管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_20.pdf
470,2014-04-01,华海药业财务报告管理制度,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_19.pdf
471,2014-04-01,华海药业：浙商证券股份有限公司关于公司使用部分闲置募集资金暂时补充流动资金的专项核查意见,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_32.pdf
472,2014-04-01,华海药业：浙商证券股份有限公司关于公司2013年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_16.pdf
473,2014-04-01,华海药业：浙商证券股份有限公司关于公司2013年度持续督导年度报告书,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_31.pdf
474,2014-04-01,华海药业：天健会计师事务所关于浙江华海药业股份有限公司2013年度募集资金存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_14.pdf
475,2014-04-01,华海药业2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_9.pdf
476,2014-04-01,华海药业2013年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_15.pdf
477,2014-04-01,华海药业2013年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_12.pdf
478,2014-04-01,华海药业2013年度募集资金存放与实际使用情况专项报告,/disclosure/listedinfo/announcement/c/2014-03-31/600521_20140401_13.pdf
479,2014-04-04,华海药业2013年度第一期短期融资券兑付公告,/disclosure/listedinfo/announcement/c/2014-04-03/600521_20140404_1.pdf
480,2014-04-17,华海药业2013年年度股东大会资料,/disclosure/listedinfo/announcement/c/2014-04-16/600521_20140417_1.pdf
481,2014-04-23,华海药业2013年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-04-22/600521_20140423_2.pdf
482,2014-04-23,华海药业2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-04-22/600521_20140423_1.pdf
483,2014-04-28,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-27/600521_2014_1.pdf
484,2014-05-07,华海药业关于2013年度利润分配的实施公告,/disclosure/listedinfo/announcement/c/2014-05-06/600521_20140507_2.pdf
485,2014-05-13,华海药业关于子公司生产的高密度聚乙烯瓶通过美国FDA注册批准的公告,/disclosure/listedinfo/announcement/c/2014-05-12/600521_20140513_3.pdf
486,2014-05-13,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2014-05-12/600521_20140513_4.pdf
487,2014-05-13,华海药业关于为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2014-05-12/600521_20140513_2.pdf
488,2014-05-13,华海药业第五届董事会第十次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2014-05-12/600521_20140513_1.pdf
489,2014-05-21,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2014-05-20/600521_20140521_1.pdf
490,2014-06-05,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2014-06-04/600521_20140605_1.pdf
491,2014-06-24,华海药业关于大股东增持公司股份的公告,/disclosure/listedinfo/announcement/c/2014-06-23/600521_20140624_1.pdf
492,2014-06-26,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2014-06-25/600521_20140626_1.pdf
493,2014-07-01,华海药业关于委托贷款到期收回的公告,/disclosure/listedinfo/announcement/c/2014-06-30/600521_20140701_1.pdf
494,2014-07-01,华海药业关于利用闲置自有资金进行委托理财或委托贷款业务的公告,/disclosure/listedinfo/announcement/c/2014-06-30/600521_20140701_3.pdf
495,2014-07-01,华海药业关于调整股票期权激励计划行权价格的公告,/disclosure/listedinfo/announcement/c/2014-06-30/600521_20140701_4.pdf
496,2014-07-01,华海药业第五届董事会第十一次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2014-06-30/600521_20140701_2.pdf
497,2014-07-01,华海药业：浙江星海律师事务所关于浙江华海药业股份有限公司调整股票期权行权价格的法律意见书,/disclosure/listedinfo/announcement/c/2014-06-30/600521_20140701_5.pdf
498,2014-07-03,华海药业关于获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2014-07-02/600521_20140703_1.pdf
499,2014-07-05,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2014-07-04/600521_20140705_1.pdf
500,2014-08-09,华海药业第五届监事会第七次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-08/600521_20140809_3.pdf
501,2014-08-09,华海药业第五届董事会第十二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2014-08-08/600521_20140809_2.pdf
502,2014-08-09,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-08/600521_2014_zzy.pdf
503,2014-08-09,华海药业半年报,/disclosure/listedinfo/announcement/c/2014-08-08/600521_2014_z.pdf
504,2014-08-09,华海药业2014年半年度募集资金存放与实际使用情况专项报告,/disclosure/listedinfo/announcement/c/2014-08-08/600521_20140809_5.pdf
505,2014-09-04,华海药业关于与天津市医药集团有限公司签署战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2014-09-03/600521_20140904_1.pdf
506,2014-09-10,华海药业验资报告,/disclosure/listedinfo/announcement/c/2014-09-09/600521_20140910_2.pdf
507,2014-09-10,华海药业股权激励计划行权结果暨股份上市公告,/disclosure/listedinfo/announcement/c/2014-09-09/600521_20140910_1.pdf
508,2014-09-16,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2014-09-15/600521_20140916_1.pdf
509,2014-09-26,华海药业关于制剂产品左乙拉西坦片增加原料药供应商获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2014-09-25/600521_20140926_1.pdf
510,2014-09-27,华海药业关于继续使用暂时闲置的募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2014-09-26/600521_20140927_3.pdf
511,2014-09-27,华海药业第五届监事会第八次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-26/600521_20140927_2.pdf
512,2014-09-27,华海药业第五届董事会第十三次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2014-09-26/600521_20140927_1.pdf
513,2014-09-27,华海药业：浙商证券股份有限公司关于浙江华海药业股份有限公司使用暂时闲置的募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2014-09-26/600521_20140927_4.pdf
514,2014-10-16,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-15/600521_2014_3.pdf
515,2014-10-31,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2014-10-30/600521_20141031_2.pdf
516,2014-10-31,华海药业关于华海（美国）国际有限公司与天士力制药集团股份有限公司签署战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2014-10-30/600521_20141031_1.pdf
517,2014-11-04,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2014-11-03/600521_20141104_1.pdf
518,2014-11-10,华海药业关于制剂产品赖诺普利片原料药供应商变更为华海药业的补充申请获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2014-11-09/600521_20141110_1.pdf
519,2014-11-11,华海药业关于为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2014-11-10/600521_20141111_2.pdf
520,2014-11-11,华海药业第五届董事会第十五次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2014-11-10/600521_20141111_1.pdf
521,2014-12-16,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2014-12-15/600521_20141216_1.pdf
522,2014-12-16,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2014-12-15/600521_20141216_2.pdf
523,2014-12-30,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2014-12-29/600521_20141230_1.pdf
524,2014-12-31,华海药业与大理学院签订校企产学研战略合作协议的公告,/disclosure/listedinfo/announcement/c/2014-12-30/600521_20141231_1.pdf
525,2015-01-08,华海药业关于继续使用暂时闲置的募集资金购买银行理财产品的公告,/disclosure/listedinfo/announcement/c/2015-01-07/600521_20150108_1.pdf
526,2015-01-30,华海药业股权激励计划股票期权符合行权条件的公告,/disclosure/listedinfo/announcement/c/2015-01-29/600521_20150130_1.pdf
527,2015-02-10,华海药业澄清公告,/disclosure/listedinfo/announcement/c/2015-02-09/600521_20150210_1.pdf
528,2015-03-04,华海药业关于制剂产品盐酸罗匹尼罗片增加原料药供应商获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2015-03-03/600521_20150304_1.pdf
529,2015-03-10,华海药业验资报告,/disclosure/listedinfo/announcement/c/2015-03-09/600521_20150310_2.pdf
530,2015-03-10,华海药业股权激励计划行权结果暨股份上市公告,/disclosure/listedinfo/announcement/c/2015-03-09/600521_20150310_1.pdf
531,2015-03-14,华海药业与山东汉兴医药科技有限公司合作事项的公告,/disclosure/listedinfo/announcement/c/2015-03-13/600521_20150314_1.pdf
532,2015-03-14,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2015-03-13/600521_20150314_2.pdf
533,2015-03-25,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2015-03-24/600521_20150325_1.pdf
534,2015-04-01,华海药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2015-03-31/600521_20150401_1.pdf
535,2015-04-07,华海药业为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_9.pdf
536,2015-04-07,华海药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_7.pdf
537,2015-04-07,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2015-04-06/600521_2014_nzy.pdf
538,2015-04-07,华海药业年报,/disclosure/listedinfo/announcement/c/2015-04-06/600521_2014_n.pdf
539,2015-04-07,华海药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_19.pdf
540,2015-04-07,华海药业募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_6.pdf
541,2015-04-07,华海药业会计政策变更公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_5.pdf
542,2015-04-07,华海药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_8.pdf
543,2015-04-07,华海药业关于修改章程的公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_27.pdf
544,2015-04-07,华海药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_4.pdf
545,2015-04-07,华海药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_29.pdf
546,2015-04-07,华海药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_28.pdf
547,2015-04-07,华海药业独立董事关于公司对外担保情况、关联方资金往来的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_12.pdf
548,2015-04-07,华海药业独立董事关于第五届董事会第三次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_22.pdf
549,2015-04-07,华海药业独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_15.pdf
550,2015-04-07,华海药业董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_21.pdf
551,2015-04-07,华海药业第五届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_3.pdf
552,2015-04-07,华海药业第五届第三次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_2.pdf
553,2015-04-07,华海药业：浙商证券股份有限公司关于浙江华海药业股份有限公司2014年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_20.pdf
554,2015-04-07,华海药业：浙商证券股份有限公司关于华海药业股份有限公司使用部分闲置募集资金暂时补充流动资金的专项核查意见,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_25.pdf
555,2015-04-07,华海药业：募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_18.pdf
556,2015-04-07,华海药业：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_14.pdf
557,2015-04-07,华海药业2015年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_10.pdf
558,2015-04-07,华海药业2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_13.pdf
559,2015-04-07,华海药业2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-04-06/600521_20150407_16.pdf
560,2015-04-08,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2015-04-07/600521_20150408_1.pdf
561,2015-04-21,华海药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-20/600521_2015_1.pdf
562,2015-04-21,华海药业2014年年度股东大会资料,/disclosure/listedinfo/announcement/c/2015-04-20/600521_20150421_1.pdf
563,2015-04-28,华海药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-04-27/600521_20150428_1.pdf
564,2015-04-28,华海药业2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-04-27/600521_20150428_2.pdf
565,2015-04-30,华海药业关于收购长兴制药有限公司部分股权的公告,/disclosure/listedinfo/announcement/c/2015-04-29/600521_20150430_1.pdf
566,2015-05-01,华海药业拟收购股权涉及的长兴制药有限公司股东全部权益价值评估项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-04-30/600521_20150501_1.pdf
567,2015-05-08,华海药业关于制剂产品利培酮片原料药供应商及生产场地变更为华海药业的补充申请获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2015-05-07/600521_20150508_1.pdf
568,2015-05-18,华海药业关于2014年度利润分配的实施公告,/disclosure/listedinfo/announcement/c/2015-05-17/600521_20150518_1.pdf
569,2015-05-22,华海药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-05-21/600521_20150522_1.pdf
570,2015-05-29,华海药业重大事项继续停牌公告,/disclosure/listedinfo/announcement/c/2015-05-28/600521_20150529_2.pdf
571,2015-05-29,华海药业关于制剂产品左乙拉西坦缓释片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2015-05-28/600521_20150529_1.pdf
572,2015-06-05,华海药业关于重大事项继续停牌并延期复牌的公告,/disclosure/listedinfo/announcement/c/2015-06-04/600521_20150605_2.pdf
573,2015-06-05,华海药业关于制剂产品安非他酮缓释片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2015-06-04/600521_20150605_1.pdf
574,2015-06-09,华海药业未来三年（2015-2017年）股东回报规划,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_11.pdf
575,2015-06-09,华海药业前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_17.pdf
576,2015-06-09,华海药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_16.pdf
577,2015-06-09,华海药业监事会对激励对象名单核实意见,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_21.pdf
578,2015-06-09,华海药业关于重大事项复牌的公告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_25.pdf
579,2015-06-09,华海药业关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_6.pdf
580,2015-06-09,华海药业关于非公开发行股票摊薄即期回报的风险提示及填补措施的公告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_8.pdf
581,2015-06-09,华海药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_13.pdf
582,2015-06-09,华海药业非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_7.pdf
583,2015-06-09,华海药业独立董事关于公司第五届董事会第十七次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_14.pdf
584,2015-06-09,华海药业独立董事公开征集委托投票权报告书,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_5.pdf
585,2015-06-09,华海药业第五届监事会第十一次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_2.pdf
586,2015-06-09,华海药业第五届董事会第十七次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_1.pdf
587,2015-06-09,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司限制性股票激励计划的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_10.pdf
588,2015-06-09,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司2015年限制性股票激励计划（草案）之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_9.pdf
589,2015-06-09,华海药业《浙江华海药业股份有限公司章程》修正案,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_12.pdf
590,2015-06-09,华海药业2015年员工持股计划管理细则,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_20.pdf
591,2015-06-09,华海药业2015年员工持股计划（草案）摘要,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_19.pdf
592,2015-06-09,华海药业2015年员工持股计划（草案）,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_18.pdf
593,2015-06-09,华海药业2015年限制性股票激励计划考核管理办法,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_22.pdf
594,2015-06-09,华海药业2015年限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_24.pdf
595,2015-06-09,华海药业2015年限制性股票激励计划（草案）摘要,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_4.pdf
596,2015-06-09,华海药业2015年限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_23.pdf
597,2015-06-09,华海药业2015年度非公开发行股票预案,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_3.pdf
598,2015-06-09,华海药业2015年度非公开发行股票募集资金使用可行性分析报告,/disclosure/listedinfo/announcement/c/2015-06-08/600521_20150609_15.pdf
599,2015-06-10,华海药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2015-06-09/600521_20150610_1.pdf
600,2015-06-10,华海药业关于修改章程的公告,/disclosure/listedinfo/announcement/c/2015-06-09/600521_20150610_2.pdf
601,2015-06-10,华海药业关于2015年第一次临时股东大会更正补充公告,/disclosure/listedinfo/announcement/c/2015-06-09/600521_20150610_4.pdf
602,2015-06-10,华海药业2015年员工持股计划（草案）摘要,/disclosure/listedinfo/announcement/c/2015-06-09/600521_20150610_3.pdf
603,2015-06-11,华海药业关于为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2015-06-10/600521_20150611_2.pdf
604,2015-06-11,华海药业第五届董事会第十八次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-06-10/600521_20150611_1.pdf
605,2015-06-12,华海药业关于制剂产品缬沙坦片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2015-06-11/600521_20150612_1.pdf
606,2015-06-12,华海药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-06-11/600521_20150612_2.pdf
607,2015-06-12,华海药业：关于浙江华海药业股份有限公司股票交易异常波动的问询复函,/disclosure/listedinfo/announcement/c/2015-06-11/600521_20150612_3.pdf
608,2015-06-20,华海药业董事会关于召开2015年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-06-19/600521_20150620_2.pdf
609,2015-06-20,华海药业2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-06-19/600521_20150620_1.pdf
610,2015-06-26,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司实施员工持股计划的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-25/600521_20150626_1.pdf
611,2015-06-27,华海药业股票期权激励计划限售股上市流通公告,/disclosure/listedinfo/announcement/c/2015-06-26/600521_20150627_1.pdf
612,2015-06-30,华海药业关于向激励对象授予限制性股票的公告,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_5.pdf
613,2015-06-30,华海药业关于华海（美国）国际有限公司与寿光富康制药有限公司签署战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_2.pdf
614,2015-06-30,华海药业独立董事关于向激励对象授予限制性股票的独立意见,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_8.pdf
615,2015-06-30,华海药业第五届监事会第十二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_4.pdf
616,2015-06-30,华海药业第五届董事会第十九次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_6.pdf
617,2015-06-30,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司股权激励计划所涉限制性股票授予的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_7.pdf
618,2015-06-30,华海药业2015年限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_9.pdf
619,2015-06-30,华海药业2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_1.pdf
620,2015-06-30,华海药业2015年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-29/600521_20150630_3.pdf
621,2015-07-01,华海药业关于华海（美国）国际有限公司与寿光富康制药有限公司签署战略合作框架协议的补充公告,/disclosure/listedinfo/announcement/c/2015-06-30/600521_20150701_1.pdf
622,2015-07-01,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2015-06-30/600521_20150701_2.pdf
623,2015-07-07,华海药业关于与九州通医药集团股份有限公司签订《战略合作框架协议》的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600521_20150707_1.pdf
624,2015-07-07,华海药业关于大股东增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600521_20150707_2.pdf
625,2015-07-08,华海药业关于控股股东增持公司股份的补充公告,/disclosure/listedinfo/announcement/c/2015-07-07/600521_20150708_1.pdf
626,2015-07-08,华海药业关于股价异动暨停牌核查的公告,/disclosure/listedinfo/announcement/c/2015-07-07/600521_20150708_2.pdf
627,2015-07-09,华海药业关于公司股票复牌的公告,/disclosure/listedinfo/announcement/c/2015-07-08/600521_20150709_2.pdf
628,2015-07-09,华海药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-08/600521_20150709_1.pdf
629,2015-07-21,华海药业2015年半年度业绩预增公告,/disclosure/listedinfo/announcement/c/2015-07-20/600521_20150721_1.pdf
630,2015-08-04,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2015-08-04/600521_20150804_1.pdf
631,2015-08-04,华海药业第五届董事会第二十次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-04/600521_20150804_2.pdf
632,2015-08-06,华海药业关于获得创新药盐酸羟哌吡酮临床批件的公告,/disclosure/listedinfo/announcement/c/2015-08-06/600521_20150806_1.pdf
633,2015-08-20,华海药业关于华海（美国）国际有限公司与浙江普洛康裕制药有限公司签署战略合作框架协议,/disclosure/listedinfo/announcement/c/2015-08-20/600521_20150820_1.pdf
634,2015-08-21,华海药业关于变更持续督导保荐机构和保荐代表人的公告,/disclosure/listedinfo/announcement/c/2015-08-21/600521_20150821_5.pdf
635,2015-08-21,华海药业第五届监事会第十三次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-21/600521_20150821_3.pdf
636,2015-08-21,华海药业第五届董事会第二十一次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-08-21/600521_20150821_2.pdf
637,2015-08-21,华海药业半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-21/600521_2015_zzy.pdf
638,2015-08-21,华海药业半年报,/disclosure/listedinfo/announcement/c/2015-08-21/600521_2015_z.pdf
639,2015-08-21,华海药业：浙商证券股份有限公司关于浙江华海药业股份有限公司2013年公开增发股票之保荐总结报告书,/disclosure/listedinfo/announcement/c/2015-08-21/600521_20150821_7.pdf
640,2015-08-21,华海药业2015年半年度募集资金存放与实际使用情况专项报告,/disclosure/listedinfo/announcement/c/2015-08-21/600521_20150821_4.pdf
641,2015-08-22,华海药业关于华海（美国）国际有限公司与浙江普洛康裕制药有限公司签署战略合作框架协议的补充公告,/disclosure/listedinfo/announcement/c/2015-08-22/600521_20150822_1.pdf
642,2015-08-29,华海药业关于收到中国证监会《行政许可申请受理通知书》的公告,/disclosure/listedinfo/announcement/c/2015-08-29/600521_20150829_1.pdf
643,2015-09-02,华海药业关于制剂产品艾司西酞普兰片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2015-09-02/600521_20150902_1.pdf
644,2015-09-03,华海药业限制性股票授予登记完成公告,/disclosure/listedinfo/announcement/c/2015-09-03/600521_20150903_1.pdf
645,2015-09-08,华海药业验资报告,/disclosure/listedinfo/announcement/c/2015-09-08/600521_20150908_1.pdf
646,2015-09-12,华海药业关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2015-09-12/600521_20150912_2.pdf
647,2015-09-12,华海药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-09-12/600521_20150912_3.pdf
648,2015-09-12,华海药业第五届董事会第二十二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-09-12/600521_20150912_1.pdf
649,2015-09-19,华海药业第五届董事会第二十三次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-09-19/600521_20150919_1.pdf
650,2015-10-13,华海药业2015年前三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2015-10-13/600521_20151013_1.pdf
651,2015-10-23,华海药业为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2015-10-23/600521_20151023_3.pdf
652,2015-10-23,华海药业第五届董事会第二十四次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-10-23/600521_20151023_2.pdf
653,2015-10-23,华海药业第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-23/600521_2015_3.pdf
654,2015-11-13,华海药业关于坎地沙坦酯片注册申请不被批准情况的公告,/disclosure/listedinfo/announcement/c/2015-11-13/600521_20151113_6.pdf
655,2015-11-14,华海药业关于坎地沙坦酯片注册申请不被批准情况的补充公告,/disclosure/listedinfo/announcement/c/2015-11-14/600521_20151114_1.pdf
656,2015-11-30,华海药业关于撤回米格列奈钙片等八个药品注册申请的提示性公告,/disclosure/listedinfo/announcement/c/2015-11-30/600521_20151130_1.pdf
657,2015-12-04,华海药业关于收到《中国证监会行政许可项目审查反馈意见通知书》的公告,/disclosure/listedinfo/announcement/c/2015-12-04/600521_20151204_1.pdf
658,2015-12-04,华海药业澄清公告,/disclosure/listedinfo/announcement/c/2015-12-04/600521_20151204_2.pdf
659,2015-12-22,华海药业关于控股子公司长兴制药股份有限公司在全国中小企业股份转让系统挂牌获批的公告,/disclosure/listedinfo/announcement/c/2015-12-22/600521_20151222_1.pdf
660,2015-12-24,华海药业澄清公告,/disclosure/listedinfo/announcement/c/2015-12-24/600521_20151224_1.pdf
661,2015-12-29,华海药业关于最近五年未被证券监管部门和交易所处罚或采取监管措施的公告,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_5.pdf
662,2015-12-29,华海药业关于非公开发行股票摊薄即期回报的风险提示及填补措施的公告（修订版）,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_3.pdf
663,2015-12-29,华海药业关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_8.pdf
664,2015-12-29,华海药业关于调整非公开发行A股股票方案的公告,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_4.pdf
665,2015-12-29,华海药业关于参与员工持股计划的董事、高级管理人员不存在减持情况和减持计划的公告,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_6.pdf
666,2015-12-29,华海药业关于《浙江华海药业股份有限公司非公开发行股票申请文件反馈意见》的回复,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_14.pdf
667,2015-12-29,华海药业独立董事关于公司第五届董事会第二十五次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_9.pdf
668,2015-12-29,华海药业第五届监事会第十五次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_2.pdf
669,2015-12-29,华海药业第五届董事会第二十五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_1.pdf
670,2015-12-29,华海药业2015年员工持股计划管理细则（修订版）,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_13.pdf
671,2015-12-29,华海药业2015年员工持股计划（草案）摘要（修订版）,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_12.pdf
672,2015-12-29,华海药业2015年员工持股计划（草案）（修订版）,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_11.pdf
673,2015-12-29,华海药业2015年度非公开发行股票预案（修订版）,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_7.pdf
674,2015-12-29,华海药业2015年度非公开发行股票募集资金使用可行性分析报告（修订版）,/disclosure/listedinfo/announcement/c/2015-12-29/600521_20151229_10.pdf
675,2015-12-31,华海药业关于控股子公司长兴制药股份有限公司在全国中小企业股份转让系统挂牌的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600521_20151231_1.pdf
676,2016-01-08,华海药业关于获得《药品GMP证书》的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-08/600521_20160108_1.pdf
677,2016-01-09,华海药业关于雷奈酸锶干混悬剂获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-01-09/600521_20160109_3.pdf
678,2016-01-09,华海药业关于雷米普利片获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-01-09/600521_20160109_2.pdf
679,2016-01-09,华海药业关于获得《药品GMP证书》的补充公告,/disclosure/listedinfo/announcement/c/2016-01-09/600521_20160109_1.pdf
680,2016-01-12,华海药业关于雷米普利片获得药物临床试验批件的补充公告,/disclosure/listedinfo/announcement/c/2016-01-12/600521_20160112_1.pdf
681,2016-01-22,华海药业关于媒体报道情况的说明,/disclosure/listedinfo/announcement/c/2016-01-22/600521_20160122_1.pdf
682,2016-01-28,华海药业关于普瑞巴林胶囊获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-01-28/600521_20160128_2.pdf
683,2016-01-28,华海药业2015年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2016-01-28/600521_20160128_1.pdf
684,2016-02-19,华海药业关于制剂产品缬沙坦氢氯噻嗪片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2016-02-19/600521_20160219_1.pdf
685,2016-02-26,华海药业关于他达拉非片等四个药品获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-02-26/600521_20160226_1.pdf
686,2016-02-27,华海药业关于变更与美国ONCOBIOLOGICS公司生物药合作事项的进展公告,/disclosure/listedinfo/announcement/c/2016-02-27/600521_20160227_1.pdf
687,2016-03-02,华海药业关于华海（美国）国际有限公司与力品药业（厦门）有限公司签署战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2016-03-02/600521_20160302_1.pdf
688,2016-03-08,华海药业关于华海（美国）国际有限公司与浙江医药股份有限公司签署战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2016-03-08/600521_20160308_1.pdf
689,2016-03-11,华海药业关于为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2016-03-11/600521_20160311_2.pdf
690,2016-03-11,华海药业第五届董事会第二十六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-03-11/600521_20160311_1.pdf
691,2016-03-12,华海药业独立董事关于为子公司提供担保的独立意见,/disclosure/listedinfo/announcement/c/2016-03-12/600521_20160312_1.pdf
692,2016-03-17,华海药业关于地氯雷他定片等六个药品获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-03-17/600521_20160317_1.pdf
693,2016-03-22,华海药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2016-03-22/600521_20160322_1.pdf
694,2016-03-23,华海药业募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2016-03-23/600521_20160323_4.pdf
695,2016-03-23,华海药业关于为子公司提供担保公告,/disclosure/listedinfo/announcement/c/2016-03-23/600521_20160323_3.pdf
696,2016-03-23,华海药业第五届监事会第十六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-03-23/600521_20160323_2.pdf
697,2016-03-23,华海药业第五届董事会第二十七次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-03-23/600521_20160323_1.pdf
698,2016-03-23,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司以前次募集资金的部分闲置资金暂时补充流动资金之核查意见,/disclosure/listedinfo/announcement/c/2016-03-23/600521_20160323_5.pdf
699,2016-03-31,华海药业关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2016-03-31/600521_20160331_1.pdf
700,2016-04-19,华海药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_5.pdf
701,2016-04-19,华海药业年报摘要,/disclosure/listedinfo/announcement/c/2016-04-19/600521_2015_nzy.pdf
702,2016-04-19,华海药业年报,/disclosure/listedinfo/announcement/c/2016-04-19/600521_2015_n.pdf
703,2016-04-19,华海药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_23.pdf
704,2016-04-19,华海药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_9.pdf
705,2016-04-19,华海药业关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_6.pdf
706,2016-04-19,华海药业关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_8.pdf
707,2016-04-19,华海药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_4.pdf
708,2016-04-19,华海药业关于高管辞职的公告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_7.pdf
709,2016-04-19,华海药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_20.pdf
710,2016-04-19,华海药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_17.pdf
711,2016-04-19,华海药业独立董事候选人声明（曾苏）,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_14.pdf
712,2016-04-19,华海药业独立董事候选人声明（王玉民）,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_15.pdf
713,2016-04-19,华海药业独立董事候选人声明（费忠新）,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_16.pdf
714,2016-04-19,华海药业独立董事关于关联交易事前认可的独立意见,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_25.pdf
715,2016-04-19,华海药业独立董事关于公司对外担保情况、关联方资金往来的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_13.pdf
716,2016-04-19,华海药业独立董事关于董事会换届选举的独立意见,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_12.pdf
717,2016-04-19,华海药业独立董事关于第五届董事会第四次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_11.pdf
718,2016-04-19,华海药业独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_21.pdf
719,2016-04-19,华海药业董事会审计委员会2015年度履职情况报告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_24.pdf
720,2016-04-19,华海药业第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_2.pdf
721,2016-04-19,华海药业第五届第四次董事会会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_1.pdf
722,2016-04-19,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司2015年度募集资金存放与使用情况的核查意见,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_10.pdf
723,2016-04-19,华海药业2015年度审计报告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_19.pdf
724,2016-04-19,华海药业2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-19/600521_20160419_22.pdf
725,2016-04-21,华海药业关于2015年年度股东大会更正补充公告,/disclosure/listedinfo/announcement/c/2016-04-21/600521_20160421_1.pdf
726,2016-04-27,华海药业2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-27/600521_2016_1.pdf
727,2016-05-04,华海药业关于召开2015年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-05-04/600521_20160504_1.pdf
728,2016-05-04,华海药业2015年年度股东大会资料,/disclosure/listedinfo/announcement/c/2016-05-04/600521_20160504_2.pdf
729,2016-05-11,华海药业2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-05-11/600521_20160511_1.pdf
730,2016-05-11,华海药业2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-05-11/600521_20160511_2.pdf
731,2016-05-12,华海药业与浙江华海药业股份有限公司2015年员工持股计划之附条件生效的股份认购合同之补充协议（二）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_14.pdf
732,2016-05-12,华海药业前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_9.pdf
733,2016-05-12,华海药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_6.pdf
734,2016-05-12,华海药业监事会关于员工持股计划相关事项的审核意见,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_12.pdf
735,2016-05-12,华海药业关于再次调整非公开发行A股股票方案的公告,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_8.pdf
736,2016-05-12,华海药业关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_4.pdf
737,2016-05-12,华海药业关于非公开发行股票摊薄即期回报的风险提示及公司拟采取措施的公告（二次修订版）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_7.pdf
738,2016-05-12,华海药业公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_18.pdf
739,2016-05-12,华海药业非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_5.pdf
740,2016-05-12,华海药业独立董事关于公司非公开发行股票涉及关联交易的事前认可意见,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_11.pdf
741,2016-05-12,华海药业独立董事关于公司第六届董事会第一次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_10.pdf
742,2016-05-12,华海药业第六届监事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_2.pdf
743,2016-05-12,华海药业第六届董事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_1.pdf
744,2016-05-12,华海药业2015年员工持股计划管理细则（二次修订版）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_17.pdf
745,2016-05-12,华海药业2015年员工持股计划（草案）摘要（二次修订版）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_16.pdf
746,2016-05-12,华海药业2015年员工持股计划（草案）（二次修订版）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_15.pdf
747,2016-05-12,华海药业2015年度非公开发行股票预案（二次修订版）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_3.pdf
748,2016-05-12,华海药业2015年度非公开发行股票募集资金使用可行性分析报告（二次修订版）,/disclosure/listedinfo/announcement/c/2016-05-12/600521_20160512_13.pdf
749,2016-05-20,华海药业关于制剂产品奥美沙坦酯氢氯噻嗪片暂时获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2016-05-20/600521_20160520_1.pdf
750,2016-05-26,华海药业监事会关于员工持股计划相关事项的审核意见,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_5.pdf
751,2016-05-26,华海药业关于再次调整非公开发行A股股票方案的公告,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_3.pdf
752,2016-05-26,华海药业非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_4.pdf
753,2016-05-26,华海药业独立董事关于公司非公开发行股票涉及关联交易的事前认可意见,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_11.pdf
754,2016-05-26,华海药业独立董事关于公司第六届董事会第二次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_6.pdf
755,2016-05-26,华海药业第六届监事会第二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_2.pdf
756,2016-05-26,华海药业第六届董事会第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_16.pdf
757,2016-05-26,华海药业：附条件生效的股份认购合同补充协议三,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_12.pdf
758,2016-05-26,华海药业2015年员工持股计划管理细则（三次修订版）,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_10.pdf
759,2016-05-26,华海药业2015年员工持股计划（草案）摘要（三次修订版）,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_9.pdf
760,2016-05-26,华海药业2015年员工持股计划（草案）（三次修订版）,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_8.pdf
761,2016-05-26,华海药业2015年度非公开发行股票预案（三次修订版）,/disclosure/listedinfo/announcement/c/2016-05-26/600521_20160526_7.pdf
762,2016-05-27,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2016-05-27/600521_20160527_2.pdf
763,2016-05-27,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2016-05-27/600521_20160527_1.pdf
764,2016-05-31,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2016-05-31/600521_20160531_1.pdf
765,2016-05-31,华海药业关于2015年度利润分配及转增股本实施公告,/disclosure/listedinfo/announcement/c/2016-05-31/600521_20160531_2.pdf
766,2016-06-06,华海药业关于吉非替尼片获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-06-06/600521_20160606_1.pdf
767,2016-06-07,华海药业关于实施2015年度权益分派后调整非公开发行股票发行价格及发行数量的公告,/disclosure/listedinfo/announcement/c/2016-06-07/600521_20160607_1.pdf
768,2016-06-09,华海药业股票期权激励计划限售股解锁暨上市公告,/disclosure/listedinfo/announcement/c/2016-06-09/600521_20160609_1.pdf
769,2016-06-20,华海药业关于非公开发行股票申请获得中国证券监督管理委员会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2016-06-20/600521_20160620_1.pdf
770,2016-06-25,华海药业关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_3.pdf
771,2016-06-25,华海药业关于延长非公开发行股票股东大会决议和授权有效期的公告,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_2.pdf
772,2016-06-25,华海药业关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_5.pdf
773,2016-06-25,华海药业关于公司内部业务整合、架构调整及授权公司经营管理层具体实施相关事项的公告,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_4.pdf
774,2016-06-25,华海药业股票期权激励计划限售股上市流通公告,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_9.pdf
775,2016-06-25,华海药业公司章程,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_8.pdf
776,2016-06-25,华海药业独立董事关于公司非公开发行股票涉及关联交易的事前认可意见,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_7.pdf
777,2016-06-25,华海药业独立董事关于公司第六届董事会第三次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_6.pdf
778,2016-06-25,华海药业第六届董事会第三次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-06-25/600521_20160625_1.pdf
779,2016-07-01,华海药业关于制剂产品卡托普利片原料药供应商及生产场地变更为华海药业的补充申请获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2016-07-01/600521_20160701_1.pdf
780,2016-07-07,华海药业关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-07/600521_20160707_2.pdf
781,2016-07-07,华海药业2016年第一次临时股东大会资料,/disclosure/listedinfo/announcement/c/2016-07-07/600521_20160707_1.pdf
782,2016-07-09,华海药业关于认购私募基金份额的公告,/disclosure/listedinfo/announcement/c/2016-07-09/600521_20160709_1.pdf
783,2016-07-13,华海药业2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-07-13/600521_20160713_1.pdf
784,2016-07-13,华海药业2016年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2016-07-13/600521_20160713_2.pdf
785,2016-08-04,华海药业关于私募基金份额转让给全资子公司的公告,/disclosure/listedinfo/announcement/c/2016-08-04/600521_20160804_1.pdf
786,2016-08-05,华海药业第六届监事会第三次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-08-05/600521_20160805_3.pdf
787,2016-08-05,华海药业第六届董事会第四次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-08-05/600521_20160805_2.pdf
788,2016-08-05,华海药业2016年半年度募集资金存放与实际使用情况专项报告,/disclosure/listedinfo/announcement/c/2016-08-05/600521_20160805_4.pdf
789,2016-08-05,华海药业2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-05/600521_2016_zzy.pdf
790,2016-08-05,华海药业2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-05/600521_2016_z.pdf
791,2016-08-16,华海药业关于制剂产品伏立康唑片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600521_20160816_1.pdf
792,2016-08-30,华海药业关于阿普斯特片等三个药品获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-08-30/600521_20160830_1.pdf
793,2016-09-09,华海药业关于非公开发行股票申请获得中国证监会核准批文的公告,/disclosure/listedinfo/announcement/c/2016-09-09/600521_20160909_1.pdf
794,2016-09-23,华海药业关于制剂产品福辛普利钠片、喹那普利片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_5.pdf
795,2016-09-23,华海药业关于硫酸氢氯吡格雷片获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_1.pdf
796,2016-09-23,华海药业关于公司非公开发行股票会后事项说明的公告,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_4.pdf
797,2016-09-23,华海药业关于公司非公开发行股票会后事项的说明,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_8.pdf
798,2016-09-23,华海药业第六届监事会第四次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_3.pdf
799,2016-09-23,华海药业第六届董事会第五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_2.pdf
800,2016-09-23,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司2015年非公开发行A股股票会后事项的补充法律意见书,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_6.pdf
801,2016-09-23,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司非公开发行股票会后事项的核查意见,/disclosure/listedinfo/announcement/c/2016-09-23/600521_20160923_7.pdf
802,2016-10-13,华海药业关于盐酸吡格列酮片等四个药品获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-10-13/600521_20161013_2.pdf
803,2016-10-13,华海药业关于投资设立医药健康投资管理公司的公告,/disclosure/listedinfo/announcement/c/2016-10-13/600521_20161013_1.pdf
804,2016-10-14,华海药业关于投资设立医药健康投资管理公司的补充公告,/disclosure/listedinfo/announcement/c/2016-10-14/600521_20161014_1.pdf
805,2016-10-19,华海药业非公开发行A股股票发行情况报告书,/disclosure/listedinfo/announcement/c/2016-10-19/600521_20161019_2.pdf
806,2016-10-19,华海药业非公开发行A股股票发行结果暨股份变动公告,/disclosure/listedinfo/announcement/c/2016-10-19/600521_20161019_1.pdf
807,2016-10-22,华海药业监事会关于公司2015年限制性股票激励计划相关事项的核查意见,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_13.pdf
808,2016-10-22,华海药业回购注销部分限制性股票减少注册资本通知债权人的公告,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_6.pdf
809,2016-10-22,华海药业关于召开2016年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_8.pdf
810,2016-10-22,华海药业关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_7.pdf
811,2016-10-22,华海药业关于拟回购注销2015年限制性股票激励计划部分已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_9.pdf
812,2016-10-22,华海药业公司章程,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_14.pdf
813,2016-10-22,华海药业分子公司管理制度,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_12.pdf
814,2016-10-22,华海药业独立董事关于公司第六届董事会第六次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_11.pdf
815,2016-10-22,华海药业第六届监事会第五次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_5.pdf
816,2016-10-22,华海药业第六届董事会第六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_4.pdf
817,2016-10-22,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司股权激励计划所涉限制性股票第一批解锁及回购注销部分限制性股票的事宜的法律意见书,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_10.pdf
818,2016-10-22,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司非公开发行A股股票发行过程和认购对象合规性的见证法律意见书,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_18.pdf
819,2016-10-22,华海药业：验资报告,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_17.pdf
820,2016-10-22,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司非公开发行A股股票之发行过程和认购对象合规性的报告,/disclosure/listedinfo/announcement/c/2016-10-22/600521_20161022_19.pdf
821,2016-10-28,华海药业关于使用募集资金置换预先投入的自筹资金的公告,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_3.pdf
822,2016-10-28,华海药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_5.pdf
823,2016-10-28,华海药业关于开立募集资金专项账户的公告,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_4.pdf
824,2016-10-28,华海药业独立董事关于公司第六届董事会第七次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_8.pdf
825,2016-10-28,华海药业第六届监事会第六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_2.pdf
826,2016-10-28,华海药业第六届董事会第七次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_1.pdf
827,2016-10-28,华海药业：天健会计师事务所（特殊普通合伙）关于公司以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_9.pdf
828,2016-10-28,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司以募集资金置换预先已投入募集资金项目的自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_7.pdf
829,2016-10-28,华海药业2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-28/600521_2016_3.pdf
830,2016-10-28,华海药业2015年限制性股票第一期解锁暨上市公告,/disclosure/listedinfo/announcement/c/2016-10-28/600521_20161028_11.pdf
831,2016-11-02,华海药业关于召开2016年第二次临时股东大会通知的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-02/600521_20161102_1.pdf
832,2016-11-02,华海药业关于盐酸度洛西汀肠溶胶囊获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-11-02/600521_20161102_2.pdf
833,2016-11-02,华海药业2016年第二次临时股东大会资料,/disclosure/listedinfo/announcement/c/2016-11-02/600521_20161102_3.pdf
834,2016-11-08,华海药业2016年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-11-08/600521_20161108_1.pdf
835,2016-11-08,华海药业2016年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2016-11-08/600521_20161108_2.pdf
836,2016-11-16,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2016-11-16/600521_20161116_1.pdf
837,2016-11-18,华海药业关于制剂产品盐酸强力霉素缓释片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2016-11-18/600521_20161118_1.pdf
838,2016-12-07,华海药业关于华海（美国）国际有限公司下属子公司普霖斯通制药有限公司收购夏洛特工厂的公告,/disclosure/listedinfo/announcement/c/2016-12-07/600521_20161207_1.pdf
839,2016-12-15,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2016-12-15/600521_20161215_1.pdf
840,2017-01-09,华海药业关于部分不符合激励条件的限制性股票回购注销结果公告,/disclosure/listedinfo/announcement/c/2017-01-09/600521_20170109_1.pdf
841,2017-02-22,华海药业关于临海市汛桥生产基地通过FDA认证的公告,/disclosure/listedinfo/announcement/c/2017-02-22/600521_20170222_1.pdf
842,2017-02-28,华海药业关于公司药品新纳入国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-02-28/600521_20170228_1.pdf
843,2017-03-02,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2017-03-02/600521_20170302_1.pdf
844,2017-03-11,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2017-03-11/600521_20170311_1.pdf
845,2017-03-14,华海药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2017-03-14/600521_20170314_1.pdf
846,2017-03-15,华海药业募集资金暂时补充流动资金公告,/disclosure/listedinfo/announcement/c/2017-03-15/600521_20170315_3.pdf
847,2017-03-15,华海药业第六届监事会第七次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-03-15/600521_20170315_2.pdf
848,2017-03-15,华海药业第六届董事会第八次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-03-15/600521_20170315_1.pdf
849,2017-03-15,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司使用部分闲置募集资金暂时补充流动资金之核查意见,/disclosure/listedinfo/announcement/c/2017-03-15/600521_20170315_4.pdf
850,2017-03-25,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2017-03-25/600521_20170325_1.pdf
851,2017-03-31,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2017-03-31/600521_20170331_1.pdf
852,2017-04-25,华海药业章程,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_22.pdf
853,2017-04-25,华海药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_11.pdf
854,2017-04-25,华海药业监事会关于公司2015年限制性股票激励计划相关事项的核查意见,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_20.pdf
855,2017-04-25,华海药业回购注销部分限制性股票减少注册资本通知债权人的公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_4.pdf
856,2017-04-25,华海药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_10.pdf
857,2017-04-25,华海药业关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_7.pdf
858,2017-04-25,华海药业关于拟回购注销2015年限制性股票激励计划部分已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_3.pdf
859,2017-04-25,华海药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_6.pdf
860,2017-04-25,华海药业关于更换部分监事的公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_8.pdf
861,2017-04-25,华海药业关于对外投资设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_5.pdf
862,2017-04-25,华海药业关于变更持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_9.pdf
863,2017-04-25,华海药业独立董事关于公司对外担保情况、关联方资金往来的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_24.pdf
864,2017-04-25,华海药业独立董事关于第六届董事会第一次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_16.pdf
865,2017-04-25,华海药业独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_17.pdf
866,2017-04-25,华海药业董事会审计委员会2016年度履职情况报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_18.pdf
867,2017-04-25,华海药业第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_2.pdf
868,2017-04-25,华海药业第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_1.pdf
869,2017-04-25,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司股权激励计划所涉回购注销部分限制性股票事宜的法律意见书,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_15.pdf
870,2017-04-25,华海药业：天健会计师事务所关于浙江华海药业股份有限公司募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_28.pdf
871,2017-04-25,华海药业：天健会计师事务所关于公司非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_26.pdf
872,2017-04-25,华海药业：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_29.pdf
873,2017-04-25,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司非公开发行之2016年度持续督导年度报告书,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_19.pdf
874,2017-04-25,华海药业：华英证券有限责任公司关于浙江华海药业股份有限公司2016年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_21.pdf
875,2017-04-25,华海药业：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_25.pdf
876,2017-04-25,华海药业2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_2017_1.pdf
877,2017-04-25,华海药业2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-25/600521_2016_nzy.pdf
878,2017-04-25,华海药业2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_2016_n.pdf
879,2017-04-25,华海药业2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-25/600521_20170425_27.pdf
880,2017-04-28,华海药业关于制剂产品奥美沙坦酯氢氯噻嗪片获得美国FDA正式批准文号的公告,/disclosure/listedinfo/announcement/c/2017-04-28/600521_20170428_1.pdf
881,2017-05-06,华海药业关于制剂产品替米沙坦片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-05-06/600521_20170506_1.pdf
882,2017-05-10,华海药业关于召开2016年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-10/600521_20170510_2.pdf
883,2017-05-10,华海药业2016年年度股东大会资料,/disclosure/listedinfo/announcement/c/2017-05-10/600521_20170510_1.pdf
884,2017-05-17,华海药业2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-05-17/600521_20170517_1.pdf
885,2017-05-17,华海药业2016年年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-05-17/600521_20170517_2.pdf
886,2017-05-25,华海药业关于制剂产品度洛西汀肠溶胶囊获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-05-25/600521_20170525_1.pdf
887,2017-05-26,华海药业关于制剂产品度洛西汀肠溶胶囊获得美国FDA批准文号的更正公告,/disclosure/listedinfo/announcement/c/2017-05-26/600521_20170526_1.pdf
888,2017-05-27,华海药业关于为子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2017-05-27/600521_20170527_2.pdf
889,2017-05-27,华海药业独立董事关于为子公司提供担保的独立意见,/disclosure/listedinfo/announcement/c/2017-05-27/600521_20170527_3.pdf
890,2017-05-27,华海药业第六届董事会第九次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-05-27/600521_20170527_1.pdf
891,2017-06-01,华海药业关于投资参股杭州多禧生物科技有限公司的公告,/disclosure/listedinfo/announcement/c/2017-06-01/600521_20170601_1.pdf
892,2017-06-06,华海药业股份质押公告,/disclosure/listedinfo/announcement/c/2017-06-06/600521_20170606_1.pdf
893,2017-06-07,华海药业2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-06-07/600521_20170607_1.pdf
894,2017-06-22,华海药业关于控股股东部分股票解除质押的公告,/disclosure/listedinfo/announcement/c/2017-06-22/600521_20170622_1.pdf
895,2017-06-23,华海药业关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2017-06-23/600521_20170623_5.pdf
896,2017-06-23,华海药业关于调整限制性股票回购价格的公告,/disclosure/listedinfo/announcement/c/2017-06-23/600521_20170623_4.pdf
897,2017-06-23,华海药业公司章程,/disclosure/listedinfo/announcement/c/2017-06-23/600521_20170623_6.pdf
898,2017-06-23,华海药业独立董事关于公司第六届董事会第十次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-06-23/600521_20170623_3.pdf
899,2017-06-23,华海药业第六届董事会第十次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-06-23/600521_20170623_1.pdf
900,2017-06-23,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司调整限制性股票回购价格相关事宜的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-23/600521_20170623_2.pdf
901,2017-06-29,华海药业关于子公司之间吸收合并的公告,/disclosure/listedinfo/announcement/c/2017-06-29/600521_20170629_1.pdf
902,2017-07-04,华海药业关于制剂产品甲磺酸帕罗西汀胶囊获得美国新泽西州联邦地方法院判决的公告,/disclosure/listedinfo/announcement/c/2017-07-04/600521_20170704_2.pdf
903,2017-07-04,华海药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-07-04/600521_20170704_1.pdf
904,2017-07-27,华海药业2017年半年度业绩快报公告,/disclosure/listedinfo/announcement/c/2017-07-27/600521_20170727_2.pdf
905,2017-08-02,华海药业关于投资设立医药健康投资管理公司的进展公告,/disclosure/listedinfo/announcement/c/2017-08-02/600521_20170802_1.pdf
906,2017-08-08,华海药业关于部分不符合激励条件的限制性股票回购注销结果公告,/disclosure/listedinfo/announcement/c/2017-08-08/600521_20170808_1.pdf
907,2017-08-10,华海药业关于子公司上海华奥泰生物药业有限公司员工股权激励框架方案及股份制改造的公告,/disclosure/listedinfo/announcement/c/2017-08-10/600521_20170810_4.pdf
908,2017-08-10,华海药业独立董事关于公司第六届董事会第十一次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-10/600521_20170810_2.pdf
909,2017-08-10,华海药业第六届监事会第八次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-08-10/600521_20170810_3.pdf
910,2017-08-10,华海药业第六届董事会第十一次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-08-10/600521_20170810_1.pdf
911,2017-08-11,华海药业关于子公司上海华奥泰生物药业有限公司员工股权激励框架方案及股份制改造的补充公告,/disclosure/listedinfo/announcement/c/2017-08-11/600521_20170811_1.pdf
912,2017-08-21,华海药业监事会关于公司2015年限制性股票激励计划相关事项的核查意见,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_5.pdf
913,2017-08-21,华海药业回购注销部分限制性股票减少注册资本通知债权人的公告,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_10.pdf
914,2017-08-21,华海药业关于修改公司章程的公告,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_7.pdf
915,2017-08-21,华海药业关于拟回购注销2015年限制性股票激励计划部分已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_9.pdf
916,2017-08-21,华海药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_6.pdf
917,2017-08-21,华海药业公司章程,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_8.pdf
918,2017-08-21,华海药业独立董事关于公司第六届董事会第十二次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_2.pdf
919,2017-08-21,华海药业第六届监事会第九次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_4.pdf
920,2017-08-21,华海药业第六届董事会第十二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_1.pdf
921,2017-08-21,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司股权激励计划所涉限制性股票第二期解锁及回购注销部分限制性股票事宜的法律意见书,/disclosure/listedinfo/announcement/c/2017-08-21/600521_20170821_3.pdf
922,2017-08-21,华海药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-21/600521_2017_zzy.pdf
923,2017-08-21,华海药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-21/600521_2017_z.pdf
924,2017-08-22,华海药业关于制剂产品帕罗西汀胶囊获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-08-22/600521_20170822_1.pdf
925,2017-08-25,华海药业2015年限制性股票第二期解锁暨上市公告,/disclosure/listedinfo/announcement/c/2017-08-25/600521_20170825_1.pdf
926,2017-09-05,华海药业关于投资参股韩国Eutilex生物科技有限公司并开展产品许可引进的公告,/disclosure/listedinfo/announcement/c/2017-09-05/600521_20170905_1.pdf
927,2017-09-06,华海药业关于投资参股韩国Eutilex生物科技有限公司并开展产品许可引进的补充公告,/disclosure/listedinfo/announcement/c/2017-09-06/600521_20170906_1.pdf
928,2017-09-19,华海药业未来三年（2017-2019年）股东回报规划,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_8.pdf
929,2017-09-19,华海药业可转换公司债券持有人会议规则,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_7.pdf
930,2017-09-19,华海药业关于为子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_13.pdf
931,2017-09-19,华海药业关于前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_12.pdf
932,2017-09-19,华海药业关于公司最近五年不存在被证券监管部门和交易所采取监管措施或处罚情况的公告,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_11.pdf
933,2017-09-19,华海药业关于公开发行可转换公司债券摊薄即期回报的风险提示及填补措施的公告,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_9.pdf
934,2017-09-19,华海药业关于本次公开发行可转换公司债券募集资金使用的可行性分析报告,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_5.pdf
935,2017-09-19,华海药业公开发行可转换公司债券预案公告,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_4.pdf
936,2017-09-19,华海药业独立董事关于公司第六届董事会第十三次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_2.pdf
937,2017-09-19,华海药业董事、高级管理人员和控股股东、实际控制人关于公司公开发行可转换公司债券后填补被摊薄即期回报措施的承诺函,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_10.pdf
938,2017-09-19,华海药业第六届监事会第十次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_3.pdf
939,2017-09-19,华海药业第六届董事会第十三次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_1.pdf
940,2017-09-19,华海药业：天健会计师事务所关于华海药业前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-09-19/600521_20170919_6.pdf
941,2017-09-28,华海药业关于川南原料药生产基地通过FDA认证的公告,/disclosure/listedinfo/announcement/c/2017-09-28/600521_20170928_1.pdf
942,2017-10-13,华海药业关于制剂产品恩替卡韦片获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-10-13/600521_20171013_1.pdf
943,2017-10-30,华海药业监事会关于公司2015年限制性股票激励计划相关事项的核查意见,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_6.pdf
944,2017-10-30,华海药业回购注销部分限制性股票减少注册资本通知债权人的公告,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_9.pdf
945,2017-10-30,华海药业关于拟投资建设临海国际医药小镇华海制药科技产业园规划项目的公告,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_10.pdf
946,2017-10-30,华海药业关于拟回购注销2015年限制性股票激励计划部分已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_7.pdf
947,2017-10-30,华海药业独立董事关于公司第六届董事会第十四次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_4.pdf
948,2017-10-30,华海药业第六届监事会第十一次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_5.pdf
949,2017-10-30,华海药业第六届董事会第十四次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_3.pdf
950,2017-10-30,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司股权激励计划所涉回购注销部分限制性股票事宜的法律意见书,/disclosure/listedinfo/announcement/c/2017-10-30/600521_20171030_8.pdf
951,2017-10-30,华海药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-30/600521_2017_3.pdf
952,2017-11-01,华海药业关于拟投资建设临海国际医药小镇华海制药科技产业园规划项目的补充公告,/disclosure/listedinfo/announcement/c/2017-11-01/600521_20171101_1.pdf
953,2017-11-02,华海药业关于制剂产品芬戈莫德胶囊获得美国FDA暂时批准文号的公告,/disclosure/listedinfo/announcement/c/2017-11-02/600521_20171102_1.pdf
954,2017-11-08,华海药业关于部分监事减持股份计划的公告,/disclosure/listedinfo/announcement/c/2017-11-08/600521_20171108_1.pdf
955,2017-11-10,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-11-10/600521_20171110_1.pdf
956,2017-11-14,华海药业关于更换保荐机构的公告,/disclosure/listedinfo/announcement/c/2017-11-14/600521_20171114_1.pdf
957,2017-12-05,华海药业关于华海（美国）国际有限公司与力品药业（厦门）有限公司合作开发产品的进展公告,/disclosure/listedinfo/announcement/c/2017-12-05/600521_20171205_1.pdf
958,2017-12-11,华海药业关于制剂产品获得美国FDA批准文号的公告,/disclosure/listedinfo/announcement/c/2017-12-11/600521_20171211_1.pdf
959,2017-12-13,华海药业关于制剂产品普瑞巴林胶囊获得美国FDA暂时批准文号的公告,/disclosure/listedinfo/announcement/c/2017-12-13/600521_20171213_1.pdf
960,2017-12-14,华海药业关于股东减持股份计划的公告,/disclosure/listedinfo/announcement/c/2017-12-14/600521_20171214_1.pdf
961,2017-12-21,华海药业关于变更保荐机构后重新签订《募集资金三方监管协议》的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600521_20171221_1.pdf
962,2017-12-23,华海药业：中信证券股份有限公司关于浙江华海药业股份有限公司2017年持续督导工作现场检查报告,/disclosure/listedinfo/announcement/c/2017-12-23/600521_20171223_1.pdf
963,2017-12-25,华海药业关于公司产品注册申请进展的说明公告,/disclosure/listedinfo/announcement/c/2017-12-25/600521_20171225_1.pdf
964,2017-12-26,华海药业关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2017-12-26/600521_20171226_2.pdf
965,2017-12-26,华海药业第六届董事会第十五次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2017-12-26/600521_20171226_1.pdf
966,2018-01-03,华海药业关于公司产品通过药品一致性评价的公告,/disclosure/listedinfo/announcement/c/2018-01-03/600521_20180103_1.pdf
967,2018-01-16,华海药业监事会关于公司2015年限制性股票激励计划相关事项的核查意见,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_2.pdf
968,2018-01-16,华海药业回购注销部分限制性股票减少注册资本通知债权人的公告,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_7.pdf
969,2018-01-16,华海药业关于召开2018年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_8.pdf
970,2018-01-16,华海药业关于拟回购注销2015年限制性股票激励计划部分已获授但尚未解锁的限制性股票的公告,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_6.pdf
971,2018-01-16,华海药业独立董事关于第六届董事会第十六次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_5.pdf
972,2018-01-16,华海药业第六届监事会第十二次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_1.pdf
973,2018-01-16,华海药业第六届董事会第十六次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_3.pdf
974,2018-01-16,华海药业：浙江天册律师事务所关于浙江华海药业股份有限公司股权激励计划所涉回购注销部分限制性股票事宜的法律意见书,/disclosure/listedinfo/announcement/c/2018-01-16/600521_20180116_4.pdf
975,2018-01-19,华海药业关于子公司浙江华海天诚药业有限公司着火事故的公告,/disclosure/listedinfo/announcement/c/2018-01-19/600521_20180119_1.pdf
976,2018-01-25,华海药业关于召开2018年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2018-01-25/600521_20180125_1.pdf
977,2018-01-25,华海药业2018年第一次临时股东大会资料,/disclosure/listedinfo/announcement/c/2018-01-25/600521_20180125_2.pdf
978,2018-02-01,华海药业2018年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2018-02-01/600521_20180201_1.pdf
979,2018-02-01,华海药业2018年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2018-02-01/600521_20180201_2.pdf
980,2018-02-08,华海药业关于2017年度业绩快报的补充更正公告,/disclosure/listedinfo/announcement/c/2018-02-08/600521_20180208_2.pdf
981,2018-02-08,华海药业2017年度业绩快报公告,/disclosure/listedinfo/announcement/c/2018-02-08/600521_20180208_1.pdf
982,2018-02-09,华海药业关于为子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2018-02-09/600521_20180209_3.pdf
983,2018-02-09,华海药业独立董事关于为子公司提供担保的独立意见,/disclosure/listedinfo/announcement/c/2018-02-09/600521_20180209_2.pdf
984,2018-02-09,华海药业第六届董事会第十七次临时会议决议公告（通讯方式）,/disclosure/listedinfo/announcement/c/2018-02-09/600521_20180209_1.pdf
985,2018-02-10,华海药业：南通华宇化工科技有限公司2017年度财务报表,/disclosure/listedinfo/announcement/c/2018-02-10/600521_20180210_1.pdf
986,2018-02-12,华海药业关于制剂产品赖诺普利氢氯噻嗪片的原料药供应商及生产场地变更为华海药业的补充申请获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2018-02-12/600521_20180212_1.pdf
